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A practical synthesis of a tetrahydroaminoquinoline scaffold (12) was developed that used a stereocontrolled
aza Michael as the key reaction. Three tetrahydroquinoline alkaloid-like, tricyclic derivatives 16, 18, and
19 with different medium to macrocyclic ring skeletons were obtained, using this scaffold as the starting
material, in a modular manner. The macrocyclic compounds with an isolated olefin and an electron-deficient
olefin were obtained by ring-closing metathesis approaches. Compounds 16 and 18 are unique and contain
bridged 10- and 12-membered functionalized rings. The NMR studies of these compounds revealed interesting
information on the conformation of the bicyclic scaffolds that was dependent on the nature and the size of
the macrocyclic rings. Finally, this modular methodology, using compound 21 anchored onto the solid support,
successfully led to the generation of different macrocyclic derivatives, 23, 25, and 27 in solid-phase synthesis.
The solid-phase synthesis approach outlined in this article has the potential to generate tetrahydroquinoline-
based tricyclic compounds containing different medium to macrocyclic architectures.
Introduction
The use of small-molecule chemical probes to understand
(and dissect) protein-protein interaction-based dynamic
signaling pathways is of immense interest in the post-
genomics age.1 Small-molecule chemical probes have tre-
mendous potential to function in a highly selective and
reversible manner on proteins.2 Although there are several
advantages to developing small-molecule chemical probes,
challenges such as developing synthetic methods leading to
the high-throughput generation of structurally diverse and
complex architectures are also associated.3 As a result, this
has met with little success to date.4 Nevertheless, the demand
for small-molecule chemical probes as dissectors of protein-
protein interaction-based signaling pathways has coincided
with the need for high-throughput generation of 3-dimen-
sional (3-D) skeletally diverse natural-product-like com-
pounds.5,6 Several examples of bioactive natural products
have been shown to be modulators of protein-protein
interactions.7
To explore the natural product chemical space of alkaloid
compounds, we anticipate that natural-product-like com-
pounds synthesized containing diverse tetrahydroquinoline-
derived polycyclic skeletons will likely compete for the same
chemical territory that is currently being championed by
bioactive natural products. Synthesis of novel natural-
product-like (alkaloid-like) compounds would serve as useful
chemical probes in the dissection of protein-protein interac-
tion-based dynamic signaling networks.8 Toward this objec-
tive, herein, we report a modular solid-phase methodology
that uses an enantioenriched tetrahydroaminoquinoline scaf-
fold as a common precursor for high-throughput generation
of tetrahydroquinoline-derived, skeletally diverse, polycyclic
compounds.9 The tetrahydroquinoline is considered to be a
highly privileged scaffold where several bioactive alkaloids
(a few examples are shown in Figure 1, see 1-3) contain
this moiety.10 The aim of this present study is to populate
the 3-dimensional (3-D) chemical space around the tetrahy-
droquinoline scaffold (4, Scheme 1) to obtain stereoselective,
complex architectures functioning as alkaloid-like (natural-
product-like) small-molecule chemical probes.
Results and Discussion
The first milestone in this study was to develop a practical
enantiocontrolled synthesis of the highly versatile tetrahy-
droquinoline scaffold 4, containing orthogonal protecting
functional groups. A facile practical synthesis of this scaffold
was crucial to building a stereoselective, 3D, skeletally
diverse program. This scaffold possesses several unique
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features and includes (i) the â- and δ-amino acid function-
alities,11 (ii) the 1,2-trans-amino alcohol moiety,12 (iii) the
1,3-hydroxyl carboxylic ester,13 and (iv) a phenolic hydroxyl
group that could be utilized as an anchoring site in solid-
phase synthesis. With compound 4 used as the starting
material, the bridged tricyclic derivative 5 with an unsaturated
enamide functional group could be obtained by a ring-closing
metathesis reaction between the olefinic moiety at C3 and
the N-acryloyl functional group at N1. In a similar manner,
the replacement of the N-acryloyl group by the N-pentenoyl
moiety would provide the bridged 12-membered ring deriva-
tive 6, having the δ-amino acid functionality.
This approach could also be applied in a modular manner,
in which, the introduction of the N-pentenoyl moiety at C3
would result in a structurally different, tricyclic derivative
having a trans-fused 12-membered ring derivative with
â-amino acid functionality. Thus, with a common starting
material, it is possible to develop a modular approach to
obtain structurally different polycyclic compounds containing
medium to macrocyclic rings. Compounds 5-7 could be
further used in library generation. For example, compound
5 contains two diversity sites [R2 and R3, and the third
diversity could be easily derived from the use of an enamide
functional group (i.e., stereoselective conjugate addition,9
Diels-Alder etc.)]. Similarly, with two diversity sites on
compound 6, the use of the carboxyl group functionality
could provide the third diversity in library generation.
Compound 7 contains a functionalized trans-fused 12-
membered ring which could easily be subjected to library
generation. Thus, several polycyclic derivatives with a
variation in their 3D architectures could be envisioned, by
employing a common starting material, in the developement
of a highly diverse combinatorial chemistry program.
Scheme 2 shows our approach to obtaining the enantio-
enriched, tetrahydroquinoline scaffold 12. As an extension
to our early finding related to an aza Michael approach,9
this was the key reaction to obtain compound 11 from 10 in
a stereocontrolled manner. Compound 10 was synthesized
from 8 in several steps including (i) Sharpless enantioselec-
tive aminohydroxylation (>92% ee),14 (ii) acetonide protec-
tion, and (iii) two carbon extension via a Wittig reaction.
We were pleased to note that, as observed in a previous study
from our group,9 the aza Michael reaction was very clean
and produced the cyclic â- and δ-amino acid derivative in
high diastereomeric purity (NOE between C2-H and C4-H).
In fact, there was no sign of any trace amounts of the other
diastereomer, even when the reaction was carried out on a
large scale (∼10.0 g). A chairlike transition state (see, 13
and 14 in Scheme 2 for both the favored and disfavored
transition states) was proposed to explain the stereochemical
Figure 1. Few examples of bioactive alkaloids having a tetrahydroquinoline scaffold.
Scheme 1. Modular Approach to Obtain Diverse, Alkaloid-like, Highly Functionalized, Polycyclic Architectures
Scheme 2
a (i) Sharpless aminohydroxylation, 75%, (ii) 2-methoxypropene, PPTS 86%. b(i) LiBH4, (ii) SO3 Py, (iii) Ph3CdCHCOOEt, 65% for 2 steps, (iv) Zn/
AcOH, 67%. cLDA, -78 °C to rt, 67%. d(i) TeocCl, pyridine, 77%, (ii) H2, 10% Pd/C; SiO2, 56%, (iii) AllocCl, DIPEA, 91%.
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outcome of this aza Michael reaction. This method is highly
practical, and it allows a highly versatile, enantioenriched
tetrahydroaminoquinoline scaffold to be obtained in large
quantities. Finally, the desired compound, 12, was easily
obtained from 11 in simple high-yielding transformations.
The model studies to test the feasibility of our modular
approach to obtain different macrocyclic derivatives are
shown in Scheme 3. Compound 15, a precursor for the
bridged ring-closing metathesis containing the N-acryloyl
moiety was obtained from 12 in several steps. We were
pleased to note that, upon treatment with Grubbs’ second-
generation catalyst, ring-closing metathesis on 15 produced
the desired tricyclic product, 16, in an 80% yield. Compound
16 has a bridged 10-membered ring with an unsaturated
enamide functional group. In addition to this, it also has a
δ-amino acid functionality that could further be utilized in
diversity generating reactions. Repeating the similar se-
quence, in which the N-acryloyl moiety is replaced by the
N-pentenoyl moiety, provided the bridged 12-membered ring-
derived polycyclic derivative 18, having only a cis olefinic
functionality. The ring-closing metathesis reaction was very
fast and produced compound 18 in a high yield (80%) with
complete stereocontrol. Finally, the successful synthesis of
the trans-fused 12-membered ring-based polycyclic derivative
was also achieved in a modular manner where the N-
pentenoyl moiety was introduced at C3.
The NMR studies of compounds 16, 18, and 19, containing
medium-sized macrocyclic rings, revealed interesting infor-
mation about their conformations. For example, 15, a
precursor to compound 16, showed a NOE between C2-H
and C4-H. This indicated that the substituents at C-2, C-3,
and C-5 occupy the pseudoequatorial positions. After forma-
tion of the macrocyclic ring containing the enamide func-
tional group, there was no NOE observed between the
protons at C2-H and C4-H in compound 16. The three
substituents at C-2, C-3, and C-5 in the tricyclic derivative
16 occupy pseudoaxial positions. This information was
helpful in the understanding of the shape of the 10-membered
bridge macrocycle which appears to be perpendicular to the
tetrahydroaminoquinoline ring architecture. In contrast to this
observation, compound 18, containing the 12-membered
macrocycle, did show NOE between protons at C2-H and
C4-H, indicating that all three substituents at C-2, C-3, and
C-5 seem to occupy pseudoequatorial positions. Thus,
extending the ring size (i.e., from compound 16 to 18) seems
to play an important role in forcing the tetrahydroamino-
quinoline ring to adopt different ring conformations. Also,
it was interesting to observe that, during the ring-closing
metathesis reaction, only the cis olefin was produced in
compound 18 containing a bridged 12-membered ring
macrocycle. Finally, the third tricyclic derivative 19, having
a trans-fused 12-membered ring with the tetrahydroquinoline
moiety, retained the NOE at C2-H and C4-H. As a result,
this study helped in the prediction of the shape of the
tetrahydroaminoquinoline scaffold in which the three sub-
stituents present at C-2, C-3, and C-4 occupy pseudoequa-
torial positions. The formation of the trans olefin-based
macrocycle in compound 19 was another interesting feature
of the ring-closing metathesis reaction.
The next goal of the project was to develop a modular
solid-phase synthesis to obtain polycyclic derivatives 23, 25,
and 27 (Scheme 5). For the solid-phase synthesis, compound
20, containing a free hydroxyl group and a three carbon
spacer, was obtained from 12 (Scheme 4). This was then
immobilized onto the alkylsilyl macrobeads (500-560 µm,
1.29 mmol/g, courtesy of the Chemical Biology Program,
Broad Institute),15 where the loading was determined to be
76%, from the increase in weight containing the loaded
Scheme 3
a (i) 4-Pentenoic acid, 4-DMAP, DIC, 85%, (ii) Pd(PPh3)4, morpholine, (iii) PhCOCl, NEt3, 67% for 2 steps, (iv) TBAF, 87%, (v) acryloyl chloride, NEt3,
73%. bSecond-generation Grubbs’ catalyst, 80%. c(i) Repeat steps i-iv from a, (ii) 4-pentenoyl chloride, NEt3, 76%, dSecond-generation Grubbs’ catalyst,
72%, e(i) 4-pentenoic acid, DMAP, DIC, 85%, (ii) Pd(PPh3)4, morpholine, (iii) 4-pentenoyl chloride, NEt3, 72% for 2 steps, (iv) second-generation Grubbs’
catalyst, 98%.
Tetrahydroquinoline-Derived Polycyclic Skeletons Journal of Combinatorial Chemistry, 2006, Vol. 8, No. 5 717
product anchored onto the alkylsilyl macrobeads. With
immobilized 21 in hand, the platform was set to explore
different modular approaches using solid-phase synthesis, and
these results are shown in Scheme 5.
Compound 21 was subjected to three parallel reactions:
The first and the second sequence gave the bridged 10- and
12-membered rings 23 and 25, respectively. These sequences
involved (i) O-pentenoylation of the free hydroxyl group
(HPLC yield 99%), (ii) N-Fmoc removal (HPLC yield 98%),
(iii) N-acylation using trans-crotonoyl chloride for the first
sequence on Scheme 5 or N-pentenoylation for the second
sequence (HPLC yield 98% and 99%) (iv) N-Alloc removal
(HPLC yield >85%), and (v) N-benzoylation (HPLC yield
>80%, first diversity). These sequences gave compounds 22
and 24 which were independently subjected to RCM using
Grubbs’ second-generation catalyst (10-20 mol %). We
were pleased to observe the formation of the bridged tricyclic
products on solid support as observed in solution-phase
synthesis. After they were cleaved from the solid support,
products 23 and 25 were isolated and fully characterized. In
both cases, the overall sequence was clean and the final
products were obtained in 45 and 50% HPLC yields for 7
steps.
In the last series, the trans-fused 12-membered ring-based
polycyclic derivative 27 was obtained from 21 in a similar
manner. This modular sequence included (i) O-pentenoyla-
tion (HPLC yield 99%), (ii) N-Fmoc removal (HPLC yield
85%), (ii) N-amide formation (HPLC yield 78%, first
diversity), (iii) N-Alloc removal (HPLC yield 71%), and (iv)
N-pentenoylation (HPLC yield 81%). Subjection to RCM
conditions, followed by cleavage of the product from solid
support, produced the tricyclic derivative 27 containing a
trans-fused 12-membered ring. As observed in previous
examples, the sequence was very clean, and the final product,
27, was obtained from 21 in 7 steps with an overall yield of
57%.
Conclusion
In summary, we have described a modular approach to
obtain stereoselective and skeletally different alkaloid-like
(i.e., natural-product-like) polycyclic derivatives containing
medium to macrocyclic rings using solid-phase synthesis.
For example, compounds 23 and 25 are unique and contain
bridged 10- and 12-membered functionalized rings. Further-
more, from our developed methodology, work is in progress
to develope a high-throughput library-generation program
Scheme 4
a See the Experimental Section. b(i) (4-methoxyphenyl) diisopropylsilyl propyl polystyrene macrobeads (loading 1.29 mmol/g, 500-560 µm), 76% determined
by an increase in the weight of the loaded alkylsilyl macrobeads.
Scheme 5
a (i) 4-Pentenoic acid, DMAP, DIC, (ii) piperidine, (iii) trans-crotonoyl chloride, 2,4,6-collidine, (iv) Pd(PPh3)4, PPh3, 4-methyl morpholine, CH3CO2H,
(v) PhCOCl, 2,4,6-collidine. b(i) Second-generation Grubbs’ catalyst, (ii) HF-pyridine. c(i) 4-Pentenoic acid, DMAP, DIC, (ii) piperidine, (iii) 4-pentenoyl
chloride, 2,4,6-collidine, (iv) Pd(PPh3)4, PPh3, 4-methyl morpholine, CH3CO2H, (v) PhCOCl, 2,4,6-collidine. d(i) Second-generation Grubbs’ catalyst, (ii)
HF-pyridine. e(i) 4-Pentenoic acid, DMAP, DIC, (ii) piperidine, (iii) PhCOCl, 2,4,6-collidine, (iv) Pd(PPh3)4, PPh3, 4-methyl morpholine, CH3CO2H, (v)
4-pentenoyl chloride, 2,4,6-collidine. f(i) Second-generation Grubbs’ catalyst, (ii) HF-pyridine.
718 Journal of Combinatorial Chemistry, 2006, Vol. 8, No. 5 Prakesch et al.
that would enable rapid access to 3-D skeletally diverse,
alkaloid-like, polycyclic compounds. Finally, the presence
of a primary hydroxyl group attached to a three-carbon spacer
makes these compounds well-suited for printing onto glass
slides for the fabrication of small-molecule microarrays.16
The incorporation of these chemical entities on a microarray
will provide a unique screening chip where immobilized
small molecules can be targeted with a diverse range of
proteins.
Experimental Section
All reactions were carried out in flame-dried glassware
under an atmosphere of nitrogen with magnetic stirring. Thin-
layer chromatography (TLC) was done on EMD (Art. 5715-
7) precoated silica gel 60 F254 glass plates (layer thickness
0.25 mm). Visualization was affected with a UV lamp (254
nm) or by staining with vanillin, KMnO4, or ammonium
molybdate/ceric sulfate solution. Flash column chromatog-
raphy was performed using silica gel 60 (40-63 µm,
Silicycle) or a Biotage Horizon flash chromatography system.
Solvents were purified as follows: trace amounts of water
and oxygen from THF, DMF, and dichloromethane were
removed using columns containing activated alumina and
copper under N2. Triethylamine, pyridine, ethyl ether, and
toluene were obtained from commercial suppliers (EMD and
Aldrich) and used without further purification. NMR spectra
were recorded on a Bruker DRX 400 MHz spectrometer.
All chemical shifts are reported in parts per million (δ). 1H
NMR (400 MHz) spectra were recorded at room temperature
in CDCl3 or C6D6 solutions and referenced to residual CHCl3
(7.27 ppm) or C6H6 (7.16 ppm). Fully decoupled 13C NMR
(100 MHz) spectra were recorded in CDCl3 or C6D6
solutions. The center peaks of CDCl3 (77.0 ppm) and C6D6
(128.7 ppm) were used as the internal reference. Mass spectra
were carried out on a VG Quattro I (Micromass) mass
spectrometer equipped with a pneumatically assisted elec-
trospray ionization source, operating in positive mode. HPLC
were performed using a Hewlett-Packard (Agilent) 1100
Series equipped with a diode array detector and a NovaPack
C18 (3.9 × 300 mm) column. The enantiomeric excess was
determined by chiral HPLC, using a Hewlett-Packard (Agi-
lent) 1090 Series II liquid chromatograph equipped with a
diode array detector and a CHIRACEL-OD column. HPLC/
MS were performed using Waters equipment: Waters
micromass ZQ ESCI multimode ionization, Waters 996
photodiode array detector (254 nm), and Waters 2795
separation module with Phenomenex Spherisorb 3 ODS-2
column.
To a solution of commercially available 5-hydroxy-2-nitro-
benzaldehyde (25.00 g, 146.6 mmol) in 500 mL of anhydrous
CH2Cl2 was added the diisopropylethylamine (47 mL, 267.1
mmol) at -10 °C over a period of 10 min. During that time,
the starting material dissolved completely. Then MEM
chloride (25.00 g, 200.7 mmol) was slowly added over a
period of 20 min at -10 °C. The reaction mixture was
allowed to warm to room temperature and was stirred for
an additional 22 h. The reaction mixture was cooled to 0
°C, and a saturated solution of NaHCO3 was slowly added
(100 mL). The aqueous layer was extracted with CH2Cl2 (3
× 50 mL), and the organic layer was dried over MgSO4.
After filtration and concentration under vacuum, the crude
product was chromatographed on silica gel (eluent ) hexane/
ethyl acetate, 7/3-1/1) to give the desired compound in a
quantitative yield (37.42 g). Yellow solid. Rf: 0.43 (1/1,
hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ 10.46
(s, 1H, CHO), 8.16 (d, J ) 9.0 Hz, 1H, CHCNO2), 7.48 (s,
1H, CHCCHO), 7.33 (d, J ) 9.0 Hz, 1H, CHCCOMEM),
5.39 (s, 2H, OCH2O), 3.83 (t, J ) 4.3 Hz, 2H, OCH2CH2O),
3.55 (t, J ) 4.3 Hz, 2H, OCH2CH2O), 3.36 (s, 3H, CH3O).
13C NMR (CDCl3, 100 MHz): δ 188.3, 161.6, 142.9, 134.2,
127.1, 119.8, 116.2, 93.5, 71.4, 68.5, 59.0. LRMS: MS
(ES+) m/z ) 270.1 (M + 1).
Triethyl phosphonate acetate (39.71 g, 194.4 mmol) was
added to a suspension of sodium hydride (10.77 g, 269.2
mmol) in 760 mL of anhydrous THF at 0 °C over a period
of 10 min. The reaction mixture was stirred vigorously for
50 min at 0 °C, before a solution of above compound (38.17
g, 149.6 mmol) in 100 mL of anhydrous THF was added
over a period of 15 min via a syringe at 0 °C. Then, the
reaction mixture was stirred for an additional 4 h at 0 °C
and quenched by a reverse addition onto mixture of ice, a
saturated solution of NH4Cl, and solid NH4Cl in a large
beaker. The aqueous layer was extracted with ethyl acetate
(3 × 150 mL), and the organic layer was dried over MgSO4.
After filtration and concentration under vacuum, the crude
product was chromatographed on silica gel (eluent ) hexane/
ethyl acetate, 8/2-1/1) to give the title compound (46.22 g,
95%). Yellow oil. Rf: 0.45 (1/1 hexane/ethyl acetate). 1H
NMR (CDCl3, 400 MHz): δ 8.17 (d, J ) 15.7 Hz, 1H, CHd
CHCO2Et), 8.09 (d, J ) 9.0 Hz, 1H, CHCNO2), 7.20 (s,
1H, CHCCHO), 7.14 (dd, J ) 9.0 Hz, J ) 1.8 Hz, 1H,
CHCCOMEM), 6.30 (d, J ) 15.7 Hz, 1H, CHdCHCO2Et),
5.36 (s, 2H, OCH2O), 4.28 (q, J ) 7.0 Hz, 2H, CO2CH2-
CH3), 3.83 (t, J ) 4.5 Hz, 2H, OCH2CH2O), 3.55 (t, J )
4.5 Hz, 2H, OCH2CH2O), 3.36 (s, 3H, CH3O), 1.34 (t, J )
7.0 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3, 100 MHz): δ
165.7, 161.0, 141.9, 140.7, 133.5, 127.4, 123.3, 116.9, 116.1,
93.4, 71.4, 68.2, 60.8, 59.0, 14.2. LRMS: MS (ES+) m/z )
326.3 (M + 1).
An aqueous solution of NaOH (3.87 g, 93.8 mmol) in 225
mL of water, t-butyl hypochlorite (10.76 mL, 93.8 mmol),
and a solution of (DHQ)2PHAL (1.26 g, 1.5 mmol) in 80
mL of n-propanol were added to a solution of benzyl
carbamate (14.55 g, 95.3 mmol) in 120 mL of n-propanol at
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0 °C with 5 min of stirring between each addition. The
reaction mixture was left at room temperature for 15 min
before being cooled to 0 °C. Then a solution of 8 (10 g,
30.7 mmol) in 10 mL of n-propanol and potassium osmate
dehydrate (453 mg, 1.2 mmol) were added. After the mixture
was stirred for 4 h at 0 °C, the temperature was slowly
increased overnight; 200 mL of ethyl acetate was added, and
the aqueous layer was extracted with ethyl acetate (3 × 100
mL). The organic layer was dried over MgSO4. After
filtration and concentration under vacuum, the crude product
was chromatographed on silica gel (eluent ) hexane/ethyl
acetate, 7/3 to pure ethyl acetate) to give 8a (11.35 g, 75%).
Yellow oil. Rf: 0.20 (1/1 hexane/ethyl acetate), 0.44 (3/7
hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ 8.06
(d, J ) 9.0 Hz, 1H, CHCNO2), 7.32-7.20 (m, 5H, Ph), 7.19
(broad s, 1H, NH), 7.13 (d, J ) 2.5 Hz, 1H, CHCOMEM),
7.04 (dd, J ) 9.0 Hz, J ) 2.5 Hz, 1H, CHCHCNO2), 6.02
(broad d, J ) 8.5 Hz, 1H, CHNHCO), 5.88 (broad d, J )
9.0 Hz, 1H, CHOH), 5.26 (s, 2H, OCH2O), 5.03 (dd, J )
11.8 Hz, J ) 2.0 Hz, 1H, PhCH2OCO), 4.96 (d, J ) 11.8
Hz, 1H, PhCH2OCO), 4.60 (broad s, 1H, OH), 4.33-4.17
(m, 2H, CO2CH2CH3), 3.77-3.72 (m, 2H, OCH2CH2O),
3.49-3.45 (m, 2H, OCH2CH2O), 3.28 (s, 3H, CH3O), 1.23
(t, J ) 7.3 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3, 100
MHz): δ 172.6, 161.1, 155.2, 141.7, 138.0, 136.1, 128.5
(2C), 128.2, 128.1 (2C), 127.7, 116.9, 115.0, 93.3, 71.9, 71.4,
68.0, 67.1, 62.8, 58.9, 52.7, 14.0. LRMS: MS (ES+) m/z )
493.3 (M + 1).
2-Methoxypropene (16.56 mL, 167.7 mmol) was added to a
solution of 8a (8.26 g, 16.8 mmol) in 400 mL of toluene,
and the mixture was stirred for 15 min. Molecular sieves (4
Å, 400 mg) and pyridinium p-toluenesulfonate (215 mg, 0.84
mmol) were added to this reaction mixture. Then the mixture
was warmed to 80 °C for 2 h. The reaction mixture was
cooled, filtered, and concentrated under vacuum. The crude
product was chromatographed on silica gel (eluent ) hexane/
ethyl acetate, 7/3-1/1) to give a mixture of 9 and 9-1 (7.70
g, 86%). Yellow oil. Rf: 0.68 (3/7 hexane/ethyl acetate using
TLC silica plates neutralized with triethylamine).
A 2 M lithium borohydride solution in THF (15.23 mL, 30.5
mmol) was added to a solution of the above mixture (5.06
g, 9.5 mmol) in 200 mL of anhydrous THF at room
temperature, and the mixture was stirred for 24 h. The
reaction mixture was quenched by reverse addition onto ice-
cold saturated NH4Cl solution. The aqueous layer was
extracted with Et2O (3 × 100 mL), and the organic layer
was dried over MgSO4. After filtration and concentration
under vacuum, the crude product was chromatographed on
neutralized silica gel with hexane/triethylamine, 9/1 (eluent
) hexane/ethyl acetate, 1/1) to give two compounds (9a,
1.83 g and 9a-1, 2.42 g).
9a. Pale yellow oil. Rf: 0.41 (3/7 hexane/ethyl acetate), 0.26
(1/1 hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ
7.95 (d, J ) 9.0 Hz, 1H, CHCNO2), 7.40-7.33 (m, 6H, 5HPh
and CHCOMEM), 7.11 (dd, J ) 9.0 Hz, J ) 2.0 Hz, 1H,
CHCHCNO2), 5.56 (broad s, 1H, CHNCO), 5.33 (broad s,
2H, OCH2O), 5.23-5.17 (broad m, 2H, PhCH2OCO), 4.10-
3.99 (broad m, 2H, CH2OH), 3.89-3.82 (m, 1H, CHOCMe2),
3.83-3.79 (m, 2H, OCH2CH2O), 3.57-3.51 (m, 2H, OCH2-
CH2O), 3.35 (s, 3H, CH3O), 2.20 (broad s, 1H, OH), 1.69
(broad s, 3H, C(CH3)2), 1.60 (s, 3H, C(CH3)2). 13C NMR
(CDCl3, 100 MHz): δ 161.2, 151.7, 142.9, 139.0, 135.5,
128.1 (2C), 127.80 (2C), 127.75, 127.1, 115.2, 114.6, 95.6,
93.3, 83.7, 71.3, 68.0, 66.6, 62.4, 58.9, 57.7, 26.9, 26.0.
LRMS: MS (ES+) m/z ) 491.2 (M + 1).
9a-1. Pale yellow oil. Rf: 0.54 (3/7 hexane/ethyl acetate),
0.33 (1/1 hexane/ethyl acetate). LRMS: MS (ES+) m/z )
531.2 (M + 41). Note: Compound 9a-1 was independently
subjected to the same sequence of reactions as compound
9a to give, after 6 steps, compound 11b with similar yields
at each step.
Triethylamine (2.30 mL, 16.5 mmol) and a solution of sulfur
trioxide pyridine complex (2.67 g, 16,5 mmol) in 20 mL of
DMSO were added to a solution of alcohol 9a (2.69 g, 5.5
mmol) in 100 mL of anhydrous CH2Cl2 at 0 °C. The reaction
mixture was warmed to room temperature and stirred for 4
h. Carbethoxymethylene triphenylphosphorane was then
added (6.03 g, 16.5 mmol), and the reaction mixture was
stirred overnight. The reaction mixture was diluted CH2Cl2
(100 mL) and then washed with 100 mL of a saturated
solution of Na2CO3, followed by 200 mL of water. The
organic layer was collected and then dried over MgSO4. After
filtration and concentration under vacuum, the crude product
was chromatographed on neutralized silica gel with hexane/
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triethylamine, 9/1 (eluent ) hexane/ethyl acetate, 1/1) to give
compound 9b (1.98 g, 65%). Yellow oil. Rf: 0.41 (1/1
hexane/ethyl acetate), 0.64 (3/7 hexane/ethyl acetate), 1H
NMR (CDCl3, 400 MHz): δ 7.96 (d, J ) 8.3 Hz, 1H,
CHCNO2), 7.40-7.12 (m, 7H, 5HPh and CHCOMEM and
CHdCHCO2Et), 7.01 (d, J ) 8.3 Hz, 1H, CHCHCNO2),
6.14 (d, J ) 15.8 Hz, 1H, CHdCHCO2Et), 5.59 (broad d, J
) 4.0 Hz, CHNCO), 5.24-5.11 (broad s, 2H, OCH2O), 5.04
(broad d, J ) 12.3 Hz, 1H, PhCH2OCO), 4.73 (broad d, J
) 12.3 Hz, 1H, PhCH2OCO), 4.64 (t, J ) 4.0 Hz, 1H,
CHOCMe2), 4.22 (q, J ) 7.0 Hz, 2H, CO2CH2CH3), 3.85-
3.69 (m, 2H, OCH2CH2O), 3.56-3.45 (m, 2H, OCH2CH2O),
3.35 (s, 3H, CH3O), 1.83 (s, 3H, C(CH3)2), 1.75 (s, 3H,
C(CH3)2), 1.30 (t, J ) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR
(CDCl3, 100 MHz): δ 165.7, 161.4, 151.7, 144.0, 142.2,
138.9, 135.6, 128.2 (2C), 127.8, 127.7 (2C), 127.5, 123.5,
115.3, 114.5, 96.5, 93.4, 82.0, 71.3, 68.1, 66.7, 61.1, 60.6,
58.9, 27.2, 26.2, 14.1. LRMS: MS (ES+) m/z ) 558.58 (M
+ 1).
Zinc dust (2.25 g, 33.7 mmol) and glacial acetic acid (1.93
mL, 33.7 mmol) were added to a solution of 9b (1.98 g, 3.5
mmol) in 30 mL of anhydrous ethanol at room temperature.
The reaction mixture was stirred for 1 h and then filtered
through celite. After concentration under vacuum to remove
ethanol, a saturated solution of NaHCO3 (30 mL) was added.
The aqueous layer was extracted with Et2O (3 × 50 mL),
and the organic layer was dried over MgSO4. After filtration
and concentration under vacuum, the crude product was
chromatographed on neutralized silica gel with hexane/
triethylamine, 9/1 (eluent ) hexane/ethyl acetate, 7/3-1/1)
to give the title compound (1.26 g, 67%). Colorless oil. Rf:
0.46 (1/1 hexane/ethyl acetate). 1H NMR (CDCl3, 400
MHz): δ 7.40-7.13 (m, 5H, HPh), 6.92 (dd, J ) 15.8 Hz, J
) 4.5 Hz, 1H, CHdCHCO2Et), 6.91 (broad s, 1H,
CHCOMEM), 6.83 (dd, J ) 8.5 Hz, J ) 2.8 Hz, 1H,
CHCHCNH2), 6.55 (broad d, J ) 8.5 Hz, 1H, CHCNH2),
6.08 (d, J ) 15.8 Hz, 1H, CHdCHCO2Et), 5.08 (broad s,
2H, OCH2O), 5.02 (broad d, J ) 12.3 Hz, 1H, PhCH2OCO),
4.85 (broad d, J ) 12.3 Hz, 1H, PhCH2OCO), 4.70 (broad
s, 2H, NH2), 4.67 (d, J ) 7.0 Hz, CHNCO), 4.15 (q, J )
7.0 Hz, 2H, CO2CH2CH3), 3.77-3.72 (m, 2H, OCH2CH2O),
3.51-3.47 (m, 2H, OCH2CH2O), 3.49-3.45 (m, 1H, CHOC-
Me2), 3.32 (s, 3H, CH3O), 1.74 (broad s, 3H, C(CH3)2), 1.68
(broad s, 3H, C(CH3)2), 1.23 (t, J ) 7.0 Hz, 3H, CO2-
CH2CH3). 13C NMR (CDCl3, 100 MHz): δ 165.6, 152.5,
150.8, 143.1, 135.6, 128.1 (2C), 127.7, 127.6 (2C), 124.5,
122.6, 118.4, 116.9, 115.4, 95.6, 94.2, 80.0, 71.4, 67.1, 66.9,
61.6, 60.3, 58.7, 26.3 (broad m for 2C), 14.0. LRMS: MS
(ES+) m/z ) 529.4 (M + 1).
A 2 M solution of lithium diisopropylamide in heptane/THF/
ethylbenzene (1.16 mL, 2.3 mmol) was added in one portion
to a solution of amine 10 (1.23 g, 2.3 mmol) in 35 mL of
anhydrous THF at -78 °C. The reaction mixture was stirred
for 75 min at the same temperature and quenched via the
addition of 20 mL of a saturated solution of NH4Cl. The
aqueous layer was extracted with ethyl acetate (3 × 30 mL),
and the organic layer was dried over MgSO4. After filtration
and concentration under vacuum, the crude product was
chromatographed on neutralized silica gel with hexane/
triethylamine, 9/1 (eluent ) hexane/ethyl acetate 1/1) to give
11 (642 mg, 67%) (Figure 2). Colorless oil. Rf: 0.54 (1/1
hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ 7.42-
7.26 (m, 5H, Ph), 6.86 (broad s, 1H, MEMOC-CHdC),
6.78 (dd, J ) 8.5 Hz, J ) 2.3 Hz, 1H, CH-CHdC-N), 6.44
(d, J ) 8.5 Hz, 1H, CH-CHdC-N), 5.29 (d, J ) 12.3 Hz,
1H, PhCH2OCO), 5.20 (d, J ) 12.3 Hz, 1H, PhCH2OCO),
5.06 (broad s, 2H, OMEM), 4.47 (d, J ) 9.8 Hz, 1H, CH-
NCO), 4.42 (broad s, 1H, NH), 4.16 (2q, J ) 7.0 Hz, 2H,
CO2CH2CH3), 3.95 (td, J ) 9.8 Hz, J ) 2.5 Hz, 1H, CHCH2-
CO2Et), 3.79-3.74 (m, 2H, OMEM), 3.66 (t, J ) 9.8 Hz,
1H, CHOCMe2), 3.54-3.49 (m, 2H, OMEM), 3.34 (s, 3H,
OMEM), 2.84 (dd, J ) 16.0 Hz, J ) 2.5 Hz, 1H, CHCH2-
CO2Et), 2.38 (dd, J ) 16.0 Hz, J ) 9.8 Hz, 1H, CHCH2-
CO2Et), 1.66 (broad s, 3H, CMe2), 1.56 (s, 3H, CMe2), 1.25
(t, J ) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3, 100
MHz): δ 171.4, 154.6 (broad), 149.2, 137.0, 135.8, 128.2
(2C), 128.0 (2C), 127.9, 122.9 (broad), 115.7, 114.1 (broad),
113.8, 99.0 (broad), 94.4, 78.5 (broad), 71.4, 67.1, 66.9
(broad), 60.6, 60.1 (broad), 58.7, 52.2, 39.4, 26.1 (broad,
Figure 2. (a) NOE between H2 and H4 and (b) the minimized energy structure of compound 11.
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2C), 13.9. LRMS: MS (ES+) m/z ) 529.4 (M + 1).
Triphosgene (192 mg, 0.63 mmol) was added to the round-
bottom flask and cooled to -78 °C. This was then followed
by a slow addition of 10 mL of anhydrous CH2Cl2, and the
solution was vigorously stirred for 30 min. The 2-(trimeth-
ylsilyl) ethanol (265 µL, 1.84 mmol) was added in one
portion to the reaction mixture at -78 °C, and it was then
warmed to -10 °C. Then pyridine (150 µL, 1.84 mmol) was
added dropwise to the reaction mixture and stirred for 2 h
at -10 °C. The reaction mixture was cooled to -45 °C, and
a solution of free amine 11 (485 mg, 0.92 mmol) and pyridine
(225 µL, 2.75 mmol) in 3 mL of anhydrous CH2Cl2 was
added via cannula over a period of 5 min. The mixture was
stirred continuously for 1 h at -30 °C and for 15 min at 0
°C. When the TLC showed no starting material, the reaction
mixture was quenched via the addition of 40 mL of a
saturated solution of NaHCO3, and the aqueous layer was
extracted with CH2Cl2 (3 × 30 mL). The organic layer was
dried over MgSO4, filtered, and concentrated under vacuum,
and the crude product was chromatographed on neutralized
silica gel with hexane/triethylamine, 9/1 (eluent ) hexane/
ethyl acetate 8/2) to give 11a (470 mg, 77%) (Figure 3).
Colorless oil. Rf: 0.59 (1/1 hexane/ethyl acetate). 1H NMR
(CDCl3, 400 MHz): δ 7.44-7.23 (m, 6H, 5HPh and CH-
CHdC-N), 6.96 (dd, J ) 8.8 Hz, J ) 2.5 Hz, 1H, CH-
CHdC-N), 6.82 (broad s, 1H, MEMOC-CHdC), 5.30-
5.09 (m, 4H, 2H from OMEM and PhCH2OCO), 4.56 (broad
m, 1H, CHCH2CO2Et), 4.35-4.26 (m, 2H, TMSCH2CH2O),
4.29-4.19 (m, 1H, CH-NCO), 4.10-3.96 (m, 2H, CO2CH2-
CH3), 3.84-3.76 (m, 2H, OMEM), 3.71 (t, J ) 9.5 Hz, 1H,
CHOCMe2), 3.57-3.51 (m, 2H, OMEM), 3.37 (s, 3H,
OMEM), 2.81-2.71 (m, 2H, CHCH2CO2Et), 1.73 (broad s,
3H, CMe2), 1.57 (s, 3H, CMe2), 1.16 (t, J ) 7.0 Hz, 3H,
CO2CH2CH3), 1.06 (broad s, 2H, TMSCH2CH2O), 0.03 (s,
9H, TMS). 13C NMR (CDCl3, 100 MHz): δ 169.5, 154.8,
154.4, 153.7 (broad), 135.7, 132.6 (broad), 128.6, 128.3 (2C),
128.1 (2C), 127.9, 127.1 (broad), 113.8 (broad), 111.1
(broad), 99.5 (broad), 93.4, 80.4 (broad), 71.3, 67.4, 66.9
(broad), 64.3, 60.3, 59.5, 58.7, 54.3, 37.9 (broad), 25.8
(broad, 2C), 17.5, 13.7, -1.8 (3C). LRMS: MS (ES+) m/z
) 673.5 (M + 1).
Palladium (10 wt %) on activated carbon (63 mg) was added
to a solution of Teoc-protected amine (503 mg, 075 mmol)
in 15 mL of anhydrous ethanol and stirred for 8.5 h under a
hydrogen atmosphere. The reaction mixture was filtered
through celite and concentrated under vacuum. The crude
product was chromatographed on silica gel (eluent ) CH2-
Cl2/methanol 98/2) to give 11b (210 mg, 56%). Colorless
oil. Rf: 0.16 (98/2 CH2Cl2/methanol). 1H NMR (CDCl3, 400
MHz): δ 7.26 (broad d, J ) 8.5 Hz, 1H, CH-CHdC-N),
7.05 (d, J ) 2.5 Hz, 1H, MEMOC-CHdC), 6.89 (dd, J )
8.5 Hz, J ) 2.5 Hz, 1H, CH-CHdC-N), 5.24-5.19 (m,
2H, OMEM), 4.46-4.44 (m, 1H, CHCH2CO2Et), 4.28-4.12
(m, 2H, TMSCH2CH2O), 4.05-3.95 (m, 2H, CO2CH2CH3),
3.80-3.75 (m, 2H, OMEM), 3.65 (t, J ) 9.8 Hz, 1H,
CHOH), 3.54-3.49 (m, 2H, OMEM), 3.33 (s, 3H, OMEM),
3.20 (ddd, J ) 9.8 Hz, J ) 6.0 Hz, J ) 3.3 Hz, 1H, CHNH2),
2.74-2.64 (m, 1H, OH), 2.71 (dd, J ) 15.3 Hz, J ) 4.5 Hz,
1H, CHCH2CO2Et), 2.52 (dd, J ) 15.3 Hz, J ) 8.5 Hz, 1H,
CHCH2CO2Et), 2.01 (broad s, 2H, NH2), 1.14 (t, J ) 7.0
Hz, 3H, CO2CH2CH3), 0.99 (t, J ) 8.5 Hz, 2H, TMSCH2-
CH2O), -0.03 (s, 9H, TMS). 13C NMR (CDCl3, 100 MHz):
δ 171.9, 155.0, 154.3, 135.1, 129.3, 126.3, 114.3, 111.1, 93.5,
78.8, 71.4, 67.4, 64.2, 60.7, 58.8, 57.4, 53.0, 38.7, 17.6, 13.9,
-1.7 (3C). LRMS: MS (ES+) m/z ) 499.4 (M + 1).
N,N-Diisopropylethylamine (135 µL, 0.77 mmol, one por-
tion) and allylchloroformate (77 µL, 0.71 mmol, dropwise
addition) were added to a solution of free amine 11b (320
mg, 0.64 mmol) in 50 mL of anhydrous CH2Cl2 at -70 °C.
The reaction mixture was slowly warmed to room temper-
ature in 3 h, stirred for an additional 2.5 h, and quenched
via the addition of 40 mL of a saturated solution of NH4Cl.
The aqueous layer was extracted with CH2Cl2 (3 × 30 mL),
and the organic layer was dried over MgSO4. After filtration
and concentration under vacuum, the crude product was
chromatographed on silica gel (eluent ) CH2Cl2/methanol
98/2) to give 12 (340 mg, 91%). Colorless oil. Rf: 0.19 (1/1
hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ 7.27
(broad d, J ) 8.8 Hz, 1H, CH-CHdC-N), 6.94 (dd, J )
8.8 Hz, J ) 2.5 Hz, 1H, CH-CHdC-N), 6.92 (broad s,
1H, MEMOC-CHdC), 6.00-5.87 (m, 1H, H2CdCH-
CH2O), 5.36 (broad d, J ) 7.5 Hz, 1H, NH), 5.33 (broad d,
J ) 17.1 Hz, 1H, H2CdCH-CH2O), 5.24-5.20 (m, 1H,
H2CdCH-CH2O), 5.25-5.19 (m, 2H, OMEM), 4.70-4.62Figure 3. NOE between H2 and H4 for compound 11a.
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(m, 1H, CH-NH), 4.62 (d, J ) 5.5 Hz, 2H, H2CdCH-
CH2O), 4.62-4.56 (m, 1H, CHCH2CO2Et), 4.32-4.16 (m,
2H, OCH2CH2TMS), 4.10-3.97 (m, 2H, CO2CH2CH3), 3.93
(broad s, 1H, OH), 3.80 (dd, J ) 6.0 Hz, J ) 4.5 Hz, 2H,
OMEM), 3.61-3.54 (m, 1H, CH-OH), 3.55 (dd, J ) 6.0
Hz, J ) 4.5 Hz, 2H, OMEM), 3.36 (s, 3H, OMEM), 2.73
(dd, J ) 15.1 Hz, J ) 4.8 Hz, 1H, CHCH2CO2Et), 2.54 (dd,
J ) 15.1 Hz, J ) 8.3 Hz, 1H, CHCH2CO2Et), 1.17 (t, J )
7.0 Hz, 3H, CO2CH2CH3), 1.03 (t, J ) 8.5 Hz, 2H,
OCH2CH2TMS), 0.01 (s, 9H, TMS). 13C NMR (CDCl3, 100
MHz): δ 171.8, 156.7, 154.9, 154.4, 132.6, 131.8, 129.3,
126.7, 117.9, 114.9, 111.8, 93.6, 76.4, 71.5, 67.5, 66.0, 64.5,
60.9, 58.9, 57.1, 53.8, 38.4, 17.7, 13.9, -1.62 (3C). LRMS:
MS (ES+) m/z ) 583.4 (M + 1).
1,3-Diisopropylcarbodiimide (183 µL, 1.17 mmol), 4-pen-
tenoic acid (92.1 µL, 0.88 mmol), and 4-(dimethylamino)-
pyridine (7.2 mg, 0.06 mmol) were added at once to a
solution of alcohol 12 (340 mg, 0.58 mmol) in 5 mL of
anhydrous CH2Cl2 at room temperature. After the mixture
was stirred for 3 h 40 min, a saturated solution of Na2CO3
(10 mL) was added, and the aqueous layer was extracted
with CH2Cl2 (3 × 20 mL); the organic layer was dried over
MgSO4. After filtration and concentration under vacuum, the
crude product was chromatographed using the Biotage
chromatograph system (A ) hexane, B ) ethyl acetate,
CV)12 mL, vol fract. ) 9 mL, flow ) 6 mL/min, EQ-
[5CV] 7%B, 1CV[1] 7%B, 10CV[2] 7%B to 50%B, 10CV-
[3] 50%B) to give 12a (330 mg, 85%). Colorless oil. Rf:
0.55 (1/1 hexane/ethyl acetate). 1H NMR (CDCl3, 400
MHz): δ 7.34 (broad s, 1H, CH-CHdC-N), 7.00 (dd, J
) 8.8 Hz, J ) 2.3 Hz, 1H, CH-CHdC-N), 6.95 (s, 1H,
MEMOC-CHdC), 5.95 (ddt, J ) 16.1 Hz, J ) 10.8 Hz, J
) 5.0 Hz, 1H, H2CdCH-CH2O), 5.82 (ddt, J ) 16.6 Hz, J
) 10.0 Hz, J ) 6.0 Hz, 1H, H2CdCH-CH2CH2CO), 5.34
(broad d, J ) 16.1 Hz, 1Htrans, H2CdCH-CH2O), 5.25
(broad d, J ) 10.8 Hz, 1Hcis, H2CdCH-CH2O), 5.26 (s,
2H, OMEM), 5.14 (broad d, J ) 8.3 Hz, 1H, NH), 5.07 (dd,
J ) 16.6 Hz, J ) 1.3 Hz, 1Htrans, H2CdCH-CH2CH2CO),
5.02 (dd, J ) 10.0 Hz, J ) 1.3 Hz, 1Hcis, H2CdCH-CH2-
CH2CO), 4.98 (dd, J ) 8.3 Hz, J ) 5.0 Hz, 1H, CHOC-
OCH2), 4.90 (dt, J ) 5.0 Hz, J ) 6.5 Hz, 1H, CHCH2CO2Et),
4.83 (t, J ) 8.3 Hz, 1H, CH-NH), 4.62 (d, J ) 5.0 Hz, 2H,
H2CdCH-CH2O), 4.33-4.17 (m, 2H, OCH2CH2TMS), 4.02
(q, J ) 7.3 Hz, 2H, CO2CH2CH3), 3.84-3.80 (m, 2H,
OMEM), 3.59-3.55 (m, 2H, OMEM), 3.39 (s, 3H, OMEM),
2.57 (dd, J ) 14.6 Hz, J ) 6.5 Hz, 1H, CHCH2CO2Et),
2.49-2.42 (m, 1H, CHCH2CO2Et), 2.46 (dt, J ) 6.0 Hz, J
) 6.3 Hz, 2H, H2CdCH-CH2CH2CO), 2.39 (t, J ) 6.3 Hz,
2H, H2CdCH-CH2CH2CO), 1.18 (t, J ) 7.3 Hz, 3H, CO2-
CH2CH3), 1.04 (t, J ) 8.5 Hz, 2H, OCH2CH2TMS), 0.03 (s,
9H, TMS). 13C NMR (CDCl3, 100 MHz): δ 172.8, 169.7,
155.9, 155.1, 154.4, 136.4, 136.2, 132.5, 129.4, 127.2, 118.0,
115.7, 115.6, 112.3, 93.6, 76.1, 71.5, 67.6, 66.0, 64.7, 60.8,
59.0, 54.1, 52.1, 37.6, 33.4, 28.5, 17.7, 14.0, -1.6 (3C).
LRMS: MS (ES+) m/z ) 665.4 (M + 1).
Redistilled morpholine (44 µL, 0.50 mmol) and a catalytic
amount of tetrakis(triphenylphosphine) palladium(0) (29 mg,
0.03 mmol) were added at once to a solution of alloc-
protected amine 12a (167 mg, 0.25 mmol) in 2.5 mL of
anhydrous CH2Cl2 at room temperature. The alloc removal
was followed on TLC and was completed after 20 min of
stirring. Then, triethylamine (106 µL, 0.75 mmol) and
benzoyl chloride (59 µL, 0.50 mmol) were slowly added to
the reaction mixture. After the mixture was stirred for 25
min at room temperature, a saturated solution of Na2CO3 (5
mL) was added, and the aqueous layer was extracted with
CH2Cl2 (3 × 10 mL); the organic layer was dried over
MgSO4. After filtration and concentration under vacuum, the
crude product was chromatographed using the Biotage
chromatograph system (A ) hexane, B ) ethyl acetate,
CV)12 mL, vol fract ) 3 mL, flow ) 7 mL/min, EQ[5CV]
5%B, 1CV[1] 5%B, 10CV[2] 5%B to 30%B, 10CV[3]
30%B) to give 12b (116 mg, 67%). Colorless oil. Rf: 0.45
(1/1 hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ
7.83 (d, J ) 7.5 Hz, 2H, Ph), 7.52 (t, J ) 7.5 Hz, 1H, Ph),
7.44 (t, J ) 7.5 Hz, 2H, Ph), 7.34 (broad d, J ) 8.8 Hz, 1H,
CH-CHdC-N), 6.99 (dd, J ) 8.8 Hz, J ) 2.5 Hz, 1H,
CH-CHdC-N), 6.89 (d, J ) 2.0 Hz, 1H, MEMOC-CHd
C), 6.78 (broad d, J ) 8.3 Hz, 1H, NH), 5.68 (ddt, J ) 16.8
Hz, J ) 10.3 Hz, J ) 6.3 Hz, 1H, CH2dCH-CH2CH2CO),
5.31 (t, J ) 8.5 Hz, 1H, CH-NH), 5.20-5.15 (m, 2H,
OMEM), 5.13 (dd, J ) 8.8 Hz, J ) 5.0 Hz, 1H, CHOCO),
4.98-4.91 (m, 1H, CHCH2CO2Et), 4.94 (dd, J ) 17.1 Hz,
J ) 1.3 Hz, 1Htrans, H2CdCH-CH2CH2CO), 4.85 (d, J )
10.3 Hz, 1Hcis, H2CdCH-CH2CH2CO), 4.33-4.18 (m, 2H,
OCH2CH2TMS), 4.04-3.95 (m, 2H, CO2CH2CH3), 3.77-
3.72 (m, 2H, OMEM), 3.50-3.46 (m, 2H, OMEM), 3.29
(s, 3H, OMEM), 2.58 (dd, J ) 14.6 Hz, J ) 7.3 Hz, 1H,
CHCH2CO2Et), 2.51 (dd, J ) 14.6 Hz, J ) 6.5 Hz, 1H,
CHCH2CO2Et), 2.41 (t, J ) 7.0 Hz, 2H, H2CdCH-CH2CH2-
CO), 2.28 (dt, J ) 6.8 Hz, J ) 7.0 Hz, 2H, H2CdCH-CH2-
CH2CO), 1.16 (t, J ) 7.0 Hz, 3H, CO2CH2CH3), 1.04 (t, J
) 8.8 Hz, 2H, OCH2CH2TMS), 0.02 (s, 9H, TMS). 13C NMR
(CDCl3, 100 MHz): δ 173.4, 169.8, 167.1, 155.0, 154.3,
136.0, 133.4, 131.8, 130.3, 129.5, 128.6 (2C), 128.2, 127.0
(2C), 115.6, 115.3, 112.6, 93.6, 75.8, 71.4, 67.5, 64.7, 60.8,
58.8, 53.9, 50.9, 37.7, 33.3, 28.4, 17.6, 13.9, -1.7 (3C).
LRMS: MS (ES+) m/z ) 685.5 (M + 1). TBAF (237 µL,
0.24 mmol) was added to a solution of Teoc-protected amine
12b (108 mg, 0.16 mmol) in 5 mL of anhydrous THF at
room temperature. The reaction mixture was stirred for 25
min, and a solution of brine (10 mL) was added. The aqueous
layer was extracted with Et2O (3 × 10 mL), and the organic
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layer was dried over MgSO4. After filtration and concentra-
tion under vacuum, the crude product was chromatographed
using the Biotage chromatograph system (A ) hexane, B )
ethyl acetate, CV ) 12 mL, vol fract ) 12 mL, flow ) 6
mL/min, EQ[5CV] 10%B, 1CV[1] 105%B, 10CV[2] 10%B
to 50%B, 10CV[3] 50%B) to give 12c (74 mg, 87%). White
solid. Rf: 0.29 (1/1 hexane/ethyl acetate). 1H NMR (CDCl3,
400 MHz): δ 7.76 (dd, J ) 7.5 Hz, J ) 1.3 Hz, 2H, Ph),
7.51 (tt, J ) 7.5 Hz, J ) 1.3 Hz, 1H, Ph), 7.43 (t, J ) 7.5
Hz, 2H, Ph), 6.87-6.82 (m, 2H, CH-CHdC-NH and
MEMOC-CHdC), 6.53 (broad d, J ) 9.5 Hz, 1H, NH),
6.44 (dd, J ) 9.5 Hz, J ) 7.0 Hz, 1H, CH-CHdC-NH),
5.68 (ddt, J ) 16.8 Hz, J ) 10.3 Hz, J ) 6.3 Hz, 1H,
CH2dCH-CH2CH2CO), 5.64 (t, J ) 9.5 Hz, 1H, CH-NH),
5.14 (dd, J ) 9.5 Hz, J ) 2.5 Hz, 1H, CHOCO), 5.12-5.06
(m, 2H, OMEM), 4.95 (dd, J ) 16.8 Hz, J ) 1.5 Hz, 1Htrans,
H2CdCH-CH2CH2CO), 4.86 (dd, J ) 10.3 Hz, J ) 1.3
Hz, 1Hcis, H2CdCH-CH2CH2CO), 4.62 (broad s, 1H, NH),
4.19 (q, J ) 7.0 Hz, 2H, CO2CH2CH3), 3.90 (td, J ) 9.8
Hz, J ) 2.5 Hz, 1H, CH-CH2CO2Et), 3.76-3.73 (m, 2H,
OMEM), 3.50-3.46 (m, 2H, OMEM), 3.30 (s, 3H, OMEM),
2.69 (ddd, J ) 16.3 Hz, J ) 3.5 Hz, J ) 2.8 Hz, 1H, CHCH2-
CO2Et), 2.43 (dd, J ) 16.3 Hz, J ) 9.8 Hz, 1H, CHCH2-
CO2Et), 2.41 (t, J ) 7.0 Hz, 2H, H2CdCH-CH2CH2CO),
2.27 (dt, J ) 6.5 Hz, J ) 7.0 Hz, 2H, H2CdCH-CH2CH2-
CO), 1.29 (t, J ) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR
(CDCl3, 100 MHz): δ 173.1, 171.6, 167.9, 150.2, 138.6,
136.1, 134.0, 131.7, 128.6 (2C), 127.0 (2C), 121.3, 117.7,
116.3, 115.7, 115.6, 94.5, 72.9, 71.5, 67.4, 61.0, 58.9, 51.9,
51.8, 36.6, 33.3, 28.5, 14.1. LRMS: MS (ES+) m/z ) 541.3
(M + 1).
Triethylamine (27 µL, 0.19 mmol) and acryloyl chloride (11
µL, 0.13 mmol) were added slowly to a solution of free
amine 12c (34 mg, 0.06 mmol) in 1 mL of anhydrous CH2-
Cl2. After the mixture was stirred for 20 min at room
temperature, a saturated solution of Na2CO3 (5 mL) was
added, and the aqueous layer was extracted with CH2Cl2 (3
× 10 mL); the organic layer was dried over MgSO4. After
filtration and concentration under vacuum, the crude product
was chromatographed using the Biotage chromatograph
system (A ) hexane, B ) ethyl acetate, CV ) 12 mL, vol
fract ) 7 mL, flow ) 6 mL/min, EQ[5CV] 10%B, 1CV[1]
10%B, 10CV[2] 10%B to 50%B, 10CV[3] 50%B) to give
15 (28 mg, 73%) (Figure 4). Colorless oil. Rf: 0.17 (1/1
hexane/ethyl acetate), 0.39 (3/7 hexane/ethyl acetate). 1H
NMR (CDCl3, 400 MHz): δ 7.85 (dd, J ) 7.5 Hz, J ) 1.5
Hz, 2H, Ph), 7.52 (tt, J ) 7.5 Hz, J ) 1.5 Hz, 1H, Ph), 7.44
(t, J ) 7.5 Hz, 2H, Ph), 7.05-6.98 (m, 2H, CH-CHdC-N
and CH-CHdC-N), 6.94 (d, J ) 1.0 Hz, 1H, MEMOC-
CHdC), 6.81 (broad d, J ) 8.0 Hz, 1H, NH), 6.49 (dd, J )
16.8 Hz, J ) 3.0 Hz, 1Htrans, H2CdCHCO), 6.44 (d, J )
10.0 Hz, 1Hcis, H2CdCHCO), 5.73 (dd, J ) 16.6 Hz, J )
10.0 Hz, 1H, H2CdCHCO), 5.69 (ddt, J ) 16.8 Hz, J )
10.3 Hz, J ) 6.3 Hz, 1H, CH2dCH-CH2CH2CO), 5.28 (dd,
J ) 9.8 Hz, J ) 8.0 Hz, 1H, CH-NH), 5.25-5.19 (m, 2H,
OMEM), 5.22-5.17 (m, 1H, CHCH2CO2Et), 5.16 (dd, J )
9.8 Hz, J ) 4.8 Hz, 1H, CHOCO), 4.96 (dd, J ) 17.1 Hz,
J ) 1.5 Hz, 1Htrans, H2CdCH-CH2CH2CO), 4.85 (dd, J )
10.3 Hz, J ) 1.3 Hz, 1Hcis, H2CdCH-CH2CH2CO), 4.01
(2q, J ) 7.0 Hz, 2H, CO2CH2CH3), 3.80-3.76 (m, 2H,
OMEM), 3.54-3.50 (m, 2H, OMEM), 3.33 (s, 3H, OMEM),
2.61 (dd, J ) 14.6 Hz, J ) 5.8 Hz, 1H, CHCH2CO2Et), 2.55
(dd, J ) 14.6 Hz, J ) 7.3 Hz, 1H, CHCH2CO2Et), 2.47 (td,
J ) 7.0 Hz, J ) 1.5 Hz, 2H, H2CdCH-CH2CH2CO), 2.32
(dt, J ) 6.3 Hz, J ) 7.0 Hz, 2H, H2CdCH-CH2CH2CO),
1.18 (t, J ) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3,
100 MHz): δ 174.2, 169,8, 167.3, 164.8, 156.3, 136.0, 133.3,
132.2, 132.1, 129.4, 129.2, 128.7 (2C), 128.1, 127.2, 127.1
(2C), 115.8, 115.1, 113.2, 93.6, 76.5, 71.5, 67.7, 60.8, 59.0,
53.5, 51.9, 37.9, 33.5, 28.5, 14.0. LRMS: MS (ES+) m/z )
595.3 (M + 1).
Second-generation Grubbs catalyst (2 mg, 0.002 mmol) was
Figure 4. (a) NOEs between H2 and H4 and (b) NH and H3 for compound 15.
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added to a solution of compound 15 (13 mg, 0.022 mmol)
in 13 mL of anhydrous CH2Cl2. The reaction was followed
on TLC and was completed after 2 h of stirring at reflux.
The reaction mixture was concentrated under vacuum and
the crude product was chromatographed using the Biotage
chromatograph system (A ) hexane, B ) ethyl acetate, CV
) 12 mL, vol fract ) 3 mL, flow ) 8 mL/min, EQ[5CV]
17%B, 1CV[1] 17%B, 10CV[2] 17%B to 70%B, 10CV[3]
70%B) to give 16 (10 mg, 80%) (Figure 5). Colorless oil.
Rf ) 0.21 (3/7 hexane/ethyl acetate). 1H NMR (C6D6/CDCl3,
9/1, 400 MHz): δ 7.64 (d, J ) 9.0 Hz, 1H, CH-CHdC-
N), 7.59 (dd, J ) 7.0 Hz, 2H, Ph), 7.20-7.14 (m, 2H, Ph),
7.10 (t, J ) 7.0 Hz, 1H, Ph), 7.03 (d, J ) 2.5 Hz, 1H,
MEMOC-CHdC), 7.01 (dd, J ) 9.0 Hz, J ) 2.5 Hz, 1H,
CH-CHdC-N), 6.40 (d, J ) 12.6 Hz, 1H, N-CO-CHd
CH), 6.17 (broad d, J ) 6.5 Hz, 1H, NH), 5.49 (td, J )
12.6 Hz, J ) 4.5 Hz, 1H, N-CO-CHdCH), 5.37 (d, J )
2.5 Hz, 1H, CHOCO), 5.27 (d, J ) 6.5 Hz, 1H, CH-NH),
4.97-7.90 (m, 2H, OMEM), 4.78 (broad ddd, J ) 10.0 Hz,
J ) 4.5 Hz, J ) 2.5 Hz, 1H, CH-CH2CO2Et), 3.91-3.76
(m, 2H, CO2CH2CH3), 3.56-3.45 (m, 2H, OMEM), 3.22-
3.10 (m, 2H, OMEM), 3.28 (s, 3H, OMEM), 2.65 (qd, J )
12.6 Hz, J ) 5.5 Hz, 1H, CH2CH2CO2), 2.32 (dd, J ) 16.1
Hz, J ) 10.0 Hz, 1H, CHCH2CO2Et), 2.10 (broad ddd, J )
13.0 Hz, J ) 12.6 Hz, J ) 5.5 Hz, 1H, CH2CH2CO2), 1.94
(dd, J ) 16.1 Hz, J ) 4.5 Hz, 1H, CHCH2CO2Et), 1.88 (td,
J ) 13.0 Hz, J ) 5.0 Hz, 1H, CH2CH2CO2), 1.74 (tdd, J )
12.6 Hz, J ) 5.5 Hz, J ) 4.5 Hz, 1H, CH2CH2CO2), 0.91 (t,
J ) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3, 100
MHz): δ 171.0, 169.5, 169.4, 166.7, 155.5, 133.9, 133.3,
132.2, 129.1, 128.8 (2C), 128.2, 127.8, 127.7, 127.1 (2C),
116.9, 115.5, 93.5, 72.2, 71.5, 67.6, 61.4, 58.9, 53.2, 48.0,
34.0, 33.0, 25.5, 14.1. LRMS: MS (ES+) m/z ) 567.2 (M
+ 1).
Discussion on the Macrocyclic Ring Conformation. We
could speculate if the ring would close “above” or “below”
the molecule since it would be unable to flip between the
two structures once the ring had closed. Molecular modeling
using the quenched dynamics technique, which seems to
search out a wide variety of conformations, was performed.
The molecule was heated to 1000 degrees K, using the amber
force field, for the starting material and the two forms of
the macrocycles, and 250 structures were collected at 0.5 ps
intervals. After all the structures were minimized and sorted
according to energy, the two forms of the macrocycle are as
shown in Figure 6.
There is a strong NOE between H2 and H8 which
confirmed the orientation of the 10-membered ring (Figure
7). As predicted, there was no NOE observed between H2
and H4.Triethylamine (6 µL, 0.044 mmol) and 4-pentenoyl
chloride (13 µL, 0.118 mmol) were added slowly to a
solution of free amine 12c (8 mg, 0.015 mmol) in 1.35 mL
of anhydrous CH2Cl2. After the mixture was stirred for 11.5
h at room temperature, a saturated solution of Na2CO3 (5
mL) was added; the aqueous layer was extracted with CH2-
Cl2 (3 × 10 mL), and the organic layer was dried over
MgSO4. After filtration and concentration under vacuum, the
crude product was chromatographed using the Biotage
Figure 5. Compound 16 has no NOE between H2 and H4.
Figure 6. Compound 16.
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chromatograph system (A ) hexane, B ) ethyl acetate, CV
) 12 mL, vol fract ) 6 mL, flow ) 7 mL/min, EQ[5CV]
10%B, 1CV[1] 10%B, 10CV[2] 10%B to 50%B, 10CV[3]
50%B) to give 17 (7.0 mg, 76%). Colorless oil. Rf: 0.21
(1/1 hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ
7.85 (d, J ) 7.5 Hz, 2H, Ph), 7.58 (t, J ) 7.5 Hz, 1H, Ph),
7.50 (t, J ) 7.5 Hz, 2H, Ph), 7.09 (broad d, J ) 8.5 Hz, 1H,
CH-CHdC-N), 7.04 (dd, J ) 8.5 Hz, J ) 2.5 Hz, 1H,
CH-CHdC-N), 6.93 (d, J ) 1.5 Hz, 1H, MEMOC-CHd
C), 6.78 (broad d, J ) 8.0 Hz, 1H, NH), 5.85-5.75 (m, 1H,
CHCH2CO2Et), 5.85 (ddt, J ) 15.1 Hz, J ) 10.0 Hz, J )
6.5 Hz, 1H, CH2dCH-CH2CH2CON), 5.70 (ddt, J ) 17.1
Hz, J ) 10.0 Hz, J ) 6.0 Hz, 1H, CH2dCH-CH2CH2COO),
5.30-5.23 (m, 1H, CH-NH), 5.27-5.20 (m, 2H, OMEM),
5.08 (dd, J ) 9.0 Hz, J ) 5.5 Hz, 1H, CHOCO), 5.04 (d, J
) 15.1 Hz, 1Htrans, H2CdCH-CH2CH2CON), 5.02 (d, J )
10.0 Hz, 1Hcis, H2CdCH-CH2CH2CON), 4.97 (dd, J ) 17.1
Hz, J ) 1.5 Hz, 1Htrans, H2CdCH-CH2CH2COO), 4.85
(broad d, J ) 10.0 Hz, 1Hcis, H2CdCH-CH2CH2COO), 4.02
(q, J ) 7.0 Hz, 2H, CO2CH2CH3), 3.81-3.77 (m, 2H,
OMEM), 3.54-3.51 (m, 2H, OMEM), 3.34 (s, 3H, OMEM),
2.57-2.50 (m, 2H, CHCH2CO2Et), 2.62-2.28 (m, 8H,
H2CdCH-CH2CH2COO and H2CdCH-CH2CH2CON), 1.19
(t, J ) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3, 100
MHz): δ 174.3, 171.7, 169.8, 167.3, 156.4, 136.9, 136.0,
133.3, 132.8, 132.1, 130.0, 128.8 (2C), 127.1 (2C), 127.0,
115.9, 115.7, 115.2, 113.1, 93.6, 76.9, 71.5, 67.7, 60.8, 59.0,
53.1, 52.1, 38.2, 33.5, 33.1, 29.5, 28.5, 14.1. LRMS: MS
(ES+) m/z ) 623.4 (M + 1).
Second-generation Grubbs catalyst (2 mg, 0.003 mmol)
was added to a solution of 17 (8.7 mg, 0.014 mmol) in 9
mL of anhydrous CH2Cl2. The reaction was followed on TLC
and was completed after 20 min of stirring at reflux. The
reaction mixture was concentrated under vacuum, and the
crude product was chromatographed using the Biotage chro-
matograph system (A ) hexane, B ) ethyl acetate, CV )
12 mL, vol fract ) 12 mL, flow ) 7 mL/min, EQ[5CV]
17%B, 1CV[1] 17%B, 10CV[2] 17%B to 70%B, 10CV[3]
70%B) to give the cyclized compound 18 (6.0 mg, 72%).
Colorless oil. Rf: 0.26 (3/7 hexane/ethyl acetate). 1H NMR
(CDCl3, 400 MHz): δ 7.64 (d, J ) 9.0 Hz, 1H, CH-CHd
C-N), 7.59 (dd, J ) 7.0 Hz, 2H, Ph), 7.20-7.14 (m, 2H,
Ph), 7.10 (t, J ) 7.0 Hz, 1H, Ph), 7.03 (d, J ) 2.5 Hz, 1H,
MEMOC-CHdC), 7.01 (dd, J ) 9.0 Hz, J ) 2.5 Hz, 1H,
CH-CHdC-N), 6.40 (d, J ) 12.6 Hz, 1H, N-CO-CHd
CH), 6.17 (broad d, J ) 6.5 Hz, 1H, NH), 5.49 (td, J )
12.6 Hz, J ) 4.5 Hz, 1H, N-CO-CHdCH), 5.37 (d, J )
2.5 Hz, 1H, CHOCO), 5.27 (d, J ) 6.5 Hz, 1H, CH-NH),
4.97-7.90 (m, 2H, OMEM), 4.78 (broad ddd, J ) 10.0 Hz,
J ) 4.5 Hz, J ) 2.5 Hz, 1H, CH-CH2CO2Et), 3.91-3.76
(m, 2H, CO2CH2CH3), 3.56-3.45 (m, 2H, OMEM), 3.22-
3.10 (m, 2H, OMEM), 3.28 (s, 3H, OMEM), 2.65 (qd, J )
12.6 Hz, J ) 5.5 Hz, 1H, CH2CH2CO2), 2.32 (dd, J ) 16.1
Hz, J ) 10.0 Hz, 1H, CHCH2CO2Et), 2.10 (broad ddd, J )
13.0 Hz, J ) 12.6 Hz, J ) 5.5 Hz, 1H, CH2CH2CO2), 1.94
(dd, J ) 16.1 Hz, J ) 4.5 Hz, 1H, CHCH2CO2Et), 1.88 (td,
J ) 13.0 Hz, J ) 5.0 Hz, 1H, CH2CH2CO2), 1.74 (tdd, J )
12.6 Hz, J ) 5.5 Hz, J ) 4.5 Hz, 1H, CH2CH2CO2), 0.91 (t,
J ) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3, 100
MHz): δ 172.6, 171.18, 171.15, 166.7, 155.2, 133.5, 131.9,
130.9, 129.3, 129.2, 129.1, 128.72, 128.65, 127.3, 127.1,
125.8, 116.9, 116.4, 93.8, 74.9, 71.5, 67.8, 61.7, 59.0, 48.6,
48.0, 35.7, 34.6, 34.0, 30.0, 27.0, 14.0. LRMS: MS (ES+)
m/z ) 595.3 (M + 1).
Redistilled morpholine (12 µL, 0.14 mmol) and a catalytic
amount of tetrakis(triphenylphosphine) palladium(0) (8 mg,
0.01 mmol) were added at once to a solution of alloc-
protected amine 12 (47 mg, 0.07 mmol) in 1.5 mL of
anhydrous CH2Cl2 at room temperature. The alloc removal
was followed on TLC and was completed after 15 min of
stirring. Then, triethylamine (30 µL, 0.21 mmol) and
4-pentenoyl chloride (16 µL, 0.14 mmol) were slowly added
to the reaction mixture. After the mixture was stirred for 1
h at room temperature, a saturated solution of Na2CO3 (5
mL) was added; the aqueous layer was extracted with CH2-
Cl2 (3 × 10 mL), and the organic layer was dried over
MgSO4. After filtration and concentration under vacuum, the
crude product was chromatographed using the Biotage
chromatograph system (A ) hexane, B ) ethyl acetate, CV
Figure 7. NOESY of compound 16.
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) 12 mL, vol fract ) 12 mL, flow ) 5 mL/min, EQ[5CV]
10%B, 1CV[1] 10%B, 10CV[2] 10%B to 50%B, 10CV[3]
50%B) to give 12d (33 mg, 72%) (Figure 8). Colorless oil.
Rf: 0.34 (1/1 hexane/ethyl acetate), 0.60 (3/7 hexane/ethyl
acetate). 1H NMR (CDCl3, 400 MHz): δ 7.33 (broad d, J )
8.8 Hz, 1H, CH-CHdC-N), 6.99 (dd, J ) 8.8 Hz, J ) 2.5
Hz, 1H, CH-CHdC-N), 6.86 (d, J ) 2.5 Hz, 1H,
MEMOC-CHdC), 5.95 (broad d, J ) 8.8 Hz, 1H, NH),
5.86 (ddt, J ) 16.3 Hz, J ) 10.3 Hz, J ) 6.0 Hz, 1H,
H2CdCHCH2CH2CONH), 5.83 (ddt, J ) 16.6 Hz, J ) 10.3
Hz, J ) 6.0 Hz, 1H, H2CdCHCH2CH2COO), 5.27-5.21
(m, 2H, OMEM), 5.13 (dd, J ) 17.1 Hz, J ) 1.5 Hz, 1Htrans,
H2CdCHCH2CH2CONH), 5.07 (dd, J ) 17.1 Hz, J ) 1.5
Hz, 1Htrans, H2CdCHCH2CH2COO), 5.06 (dd, J ) 10.3 Hz,
J ) 1.5 Hz, 1Hcis, H2CdCHCH2CH2CONH), 5.03 (dd, J )
10.3 Hz, J ) 1.5 Hz, 1Hcis, H2CdCHCH2CH2COO), 5.11
(dd, J ) 8.8 Hz, J ) 8.3 Hz, 1H, CH-NH), 4.99 (dd, J )
8.3 Hz, J ) 4.8 Hz, 1H, CHOCO), 4.92 (ddd, J ) 5.0 Hz,
J ) 7.0 Hz, J ) 6.0 Hz, 1H, CHCH2CO2Et), 4.32-4.17 (m,
2H, OCH2CH2TMS), 4.03 (2q, J ) 7.3 Hz, 2H, CO2CH2-
CH3), 3.83-3.80 (m, 2H, OMEM), 3.59-3.55 (m, 2H,
OMEM), 3.38 (s, 3H, OMEM), 2.54 (dd, J ) 14.3 Hz, J )
7.0 Hz, 1H, CHCH2CO2Et), 2.49 (dd, J ) 14.3 Hz, J ) 6.0
Hz,1H,CHCH2CO2Et),2.49-2.42(m,4H,H2CdCHCH2CH2-
COO and H2CdCHCH2CH2CONH), 2.42-2.35 (m, 4H,
H2CdCHCH2CH2COO and H2CdCHCH2CH2CONH), 1.19
(t, J ) 7.3 Hz, 3H, CO2CH2CH3), 1.04 (t, J ) 8.5 Hz, 2H,
OCH2CH2TMS), 0.03 (s, 9H, TMS). 13C NMR (CDCl3, 100
MHz): δ 173.1, 172.2, 169.9, 155.1, 154.4, 136.8, 136.2,
130.2, 129.5, 127.1, 115.9, 115.8, 115.5, 112.5, 93.7, 75.8,
71.6, 67.6, 64.8, 60.9, 59.0, 53.8, 50.2, 37.7, 35.8, 33.4, 29.4,
28.6, 17.7, 14.0, -1.6 (3C). LRMS: MS (ES+) m/z ) 663.6
(M + 1).
Second-generation Grubbs catalyst (4 mg, 0.003 mmol) was
added to a solution of compound 12d (21 mg, 0.032 mmol)
in 25 mL of anhydrous CH2Cl2. The reaction was followed
on TLC and was completed after 1 h of stirring at reflux.
The reaction mixture was concentrated under vacuum, and
the crude product was chromatographed using the Biotage
chromatograph system (A ) hexane, B ) ethyl acetate, CV
) 12 mL, vol fract ) 12 mL, flow ) 5 mL/min, EQ[5CV]
17%B, 1CV[1] 17%B, 10CV[2] 17%B to 70%B, 10CV[3]
70%B) to give compound 19 (20 mg, 98%) (Figure 9).
Colorless oil. Rf: 0.24 (3/7 hexane/ethyl acetate). 1H NMR
(CDCl3, 400 MHz): δ 7.29 (broad d, J ) 8.8 Hz, 1H, CH-
CHdC-N), 6.99 (dd, J ) 8.8 Hz, J ) 2.5 Hz, 1H, CH-
CHdC-N), 6.85 (d, J ) 2.5 Hz, 1H, MEMOC-CHdC),
5.68 (broad d, J ) 9.5 Hz, 1H, NH), 5.51-5.36 (m, J )
15.3 Hz can be read, 2H, CH2CHdCHCH2), 5.27-5.21 (m,
2H, OMEM), 5.19 (dd, J ) 10.8 Hz, J ) 9.5 Hz, 1H, CH-
NH), 4.96 (dd, J ) 10.8 Hz, J ) 5.8 Hz, 1H, CHOCO),
4.79 (broad q, J ) 6.0 Hz, 1H, CHCH2CO2Et), 4.32-4.16
(m, 2H, OCH2CH2TMS), 3.99 (q, J ) 7.0 Hz, 2H, CO2CH2-
CH3), 3.83-3.79 (m, 2H, OMEM), 3.69-3.54 (m, 2H,
OMEM), 3.39 (s, 3H, OMEM), 2.59-2.26 (m, 9H, 7H from
NHCOCH2CH2CHdCHCH2CH2 and 2H from CHCH2CO2-
Et), 2.10 (td, J ) 12.8 Hz, J ) 3.0 Hz, 1H, NHCOCH2),
1.16 (t, J ) 7.0 Hz, 3H, CO2CH2CH3), 1.04 (t, J ) 8.8 Hz,
2H, OCH2CH2TMS), 0.03 (s, 9H, TMS). 13C NMR (CDCl3,
100 MHz): δ 173.4, 172.7, 169.8, 155.2, 154.2, 131.3, 130.6,
129.9, 129.8, 127.1, 115.0, 111.4, 93.5, 75.6, 71.6, 67.6, 64.8,
60.7, 59.0, 55.1, 50.3, 38.7, 37.8, 34.4, 29.4, 28.6, 17.7, 14.0,
-1.6 (3C). LRMS: MS (ES+) m/z ) 635.3 (M + 1).
Compound 19: Stereochemistry of the Double Bond.
It is difficult to make this determination from the NMR
because the olefinic protons have almost identical chemical
Figure 8. NOEs between (a) NH and H3 and (b) H2 and H4 and (c) the minimized energy structure (HyperChem) of compound 12d.
Figure 9. NOE between H2 and H4 for compound 19.
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shifts, resulting in strong second-order effects (Figures 10
and 11).
p-Toluenesulfonic acid monohydrate (69 mg, 0.35 mmol)
was added to a solution of MEM-protected compound 12
(412 mg, 0.71 mmol) in 5 mL of anhydrous ethanol at room
temperature. The reaction mixture was stirred for 24 h at
room temperature and then at 50 °C for 7 h. An additional
batch of p-toluenesulfonic acid monohydrate (69 mg, 0.35
mmol) was added, and the solution was stirred for an
additional 20 h at 50 °C. After it was cooled to room
temperature, the reaction mixture was concentrated under
vacuum to remove the ethanol, and a saturated solution of
NH4Cl (20 mL) was added. The aqueous layer was extracted
with Et2O (3 × 40 mL), and the organic layer was dried
over MgSO4. After filtration and concentration under vacuum,
the crude product was chromatographed using the Biotage
chromatograph system (A ) hexane, B ) ethyl acetate, CV
) 12 mL, vol fract ) 6 mL, flow ) 6 mL/min, EQ[5CV]
10%B, 1CV[1] 10%B, 10CV[2] 10%B to 50%B, 10CV[3]
50%B) to give 12e (200 mg, 57%). White solid. Rf: 0.25
(1/1 hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ
7.41-7.29 (broad s, 1H, PhOH), 7.15 (broad d, J ) 8.0 Hz,
1H, CH-CHdC-N), 6.74-6.56 (broad m, 2H, CH-CHd
C-N and MEMOC-CHdC), 5.95-5.73 (m, 2H, H2Cd
CH-CH2O and NH), 5.27 (broad d, J ) 17.3 Hz, 1H, H2Cd
CH-CH2O), 5.16 (broad d, J ) 10.0 Hz, 1H, H2CdCH-
CH2O),4.65-4.50(broadm,2H,CH-NHandCHCH2CO2Et),
4.54 (broad d, J ) 5.3 Hz, 2H, H2CdCH-CH2O), 4.29 (broad
s, 1H, OH), 4.30-4.15 (broad m, 2H, OCH2CH2TMS),
4.07-3.94 (m, 2H, CO2CH2CH3), 3.60-3.47 (m, 1H, CH-
OH), 2.67 (broad dd, J ) 14.6 Hz, J ) 5.0 Hz, 1H, CHCH2-
CO2Et), 2.56 (broad dd, J ) 14.6 Hz, J ) 6.5 Hz, 1H,
CHCH2CO2Et), 1.16 (t, J ) 7.0 Hz, 3H, CO2CH2CH3), 1.02
(broad t, J ) 8.0 Hz, 2H, OCH2CH2TMS), 0.00 (s, 9H,
TMS). 13C NMR (CDCl3, 100 MHz): δ 171.9, 157.1, 154.8,
154.0, 132.4, 131.6, 127.3, 126.7, 118.0, 114.5, 110.7, 76.0,
66.1, 64.7, 61.1, 57.1, 53.8, 38.2, 17.6, 13.9, -1.6 (3C).
LRMS: MS (ES+) m/z ) 495.2 (M + 1).
3-(Tetrahydro-2H-pyran-2-yloxy)propyl 4-methylbenzene-
sulfonate (116 mg, 0.37 mmol) and 12e (130 mg, 0.26 mmol)
were added at room temperature via canula (1 mL of
anhydrous DMF was used to wash the round-bottom flasks)
to a solution of cesium carbonate (122 mg, 0.37 mmol) in 3
mL of anhydrous DMF. The reaction mixture was stirred
for 40 h at room temperature, and then the DMF was
removed under vacuum. A solution of brine (10 mL) was
then added, and the aqueous layer was extracted with Et2O
(3 × 30 mL) and CH2Cl2 (1 × 30 mL). The organic layer
was dried over MgSO4, filtered, and concentration under
vacuum. The crude product was chromatographed using the
Biotage chromatograph system (A ) hexane, B ) ethyl
acetate, CV ) 12 mL, vol fract ) 12 mL, flow ) 7 mL/
min, EQ[5CV] 10%B, 1CV[1] 10%B, 10CV[2] 10%B to
50%B, 10CV[3] 50%B) to give 12f (129 mg, 77%, a mixture
diastereomers). Colorless oil. Rf: 0.29 (1/1 hexane/ethyl
acetate). 1H NMR (CDCl3, 400 MHz): δ 7.26 (broad d, J )
Figure 10. (a) Lowest-energy conformation of 800 minimized structures with a trans olefinic moiety and (b) the lowest-energy conformation
of 800 minimized structures with a cis olefinic moiety for compound 19.
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8.8 Hz, 1H, CH-CHdC-N), 6.79 (s, 1H, MEMOC-CHd
C), 6.77 (dd, J ) 8.8 Hz, J ) 2.8 Hz, 1H, CH-CHdC-N),
6.02-5.85 (m, 1H, H2CdCH-CH2O), 5.34 (d, J ) 17.1 Hz,
1Htrans, H2CdCH-CH2O), 5.32-5.24 (m, 1H, NH), 5.23 (d,
J ) 11.1 Hz, 1Hcis, H2CdCH-CH2O), 4.70-4.60 (broad
m, 1H, OCHO), 4.63 (broad d, J ) 5.5 Hz, 2H, H2CdCH-
CH2O), 4.61-4.56 (broad m, 2H, CH-NH and CHCH2CO2-
Et), 4.31-4.16 (broad m, 2H, OCH2CH2TMS), 4.09-4.00
(m, 4H, CO2CH2CH3 and CH2OPh), 3.95-3.80 (m, 3H, CH2-
OCHO and OH), 3.60-3.53 (m, 2H, CH2CH2CH2OPh),
3.53-3.46 (m, 1H, CH-OH), 2.75 (dd, J ) 15.3 Hz, J )
5.0 Hz, 1H, CHCH2CO2Et), 2.52 (dd, J ) 15.3 Hz, J ) 8.5
Hz, 1H, CHCH2CO2Et), 2.05 (quint, J ) 6.0 Hz, 2H,
CH2CH2CH2OPh), 1.81 (qd, J ) 8.8 Hz, J ) 3.5 Hz, 1H,
CH2CHO), 1.72 (dt, J ) 12.6 Hz, J ) 3.0 Hz, 1H, CH2-
CH2CHO), 1.61-1.47 (m, 4H, 1H from CH2CHO, 1H from
CH2CH2CHO and 2H from CH2CH2O), 1.18 (t, J ) 7.3 Hz,
3H, CO2CH2CH3), 1.03 (broad t, J ) 8.8 Hz, 2H, OCH2CH2-
TMS), 0.01 (s, 9H, TMS). 13C NMR (CDCl3, 100 MHz): δ
171.9, 156.7, 154.4 (2C), 132.6, 131.83 and 131.82 (2
diastereomers), 128.1, 126.6, 117.9, 113.04 and 112.95 (2
diastereomers), 109.98 and 109.88 (2 diastereomers), 99.02
and 98.95 (2 diastereomers), 76.6, 66.0, 65.16 and 65.12 (2
diastereomers), 64.5, 63.94 and 63.92 (2 diastereomers),
62.39 and 62.34 (2 diastereomers), 61.0, 57.2, 53.8, 38.4,
30.6, 29.64 and 29.61 (2 diastereomers), 25.36 and 25.35 (2
diastereomers), 19.60 and 19.57 (2 diastereomers), 17.7, 14.0,
-1.6 (3C). LRMS: MS (ES+) m/z ) 637.3 (M + 1).
A molar solution of TBAF (405 µL, 0.40 mmol) at room
temperature was added to a solution of Teoc-protected
compound 12f (129 mg, 0.20 mmol) in 10 mL of anhydrous
THF. The reaction mixture was stirred for 25 min at room
temperature and then concentrated under vacuum. The crude
product was chromatographed using the Biotage chromato-
graph system (A ) hexane, B ) ethyl acetate, CV ) 12
mL, vol fract ) 9 mL, flow ) 7 mL/min, EQ[5CV] 10%B,
1CV[1] 10%B, 10CV[2] 10%B to 50%B, 10CV[3] 50%B)
to give 12g (84 mg, 84%). White solid. Rf: 0.27 (1/1 hexane/
ethyl acetate), 0.56 (3/7 hexane/ethyl acetate). 1H NMR
(CDCl3, 400 MHz): δ 6.74 (d, J ) 2.0 Hz, 1H, MEMOC-
Figure 11. NOEs between (a) H1 and H8, (b) H1 and H3/H7 and NH, (c) NH and H3/H4 and H4 and H2, (d) H7 and H9/H10 and H8 and
H9/H10, and (e) H9/H10 and H11 for the NOESY of compound 19.
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CHdC), 6.69 (dd, J ) 8.8 Hz, J ) 2.8 Hz, 2H, CH-CHd
C-N), 6.51 (d, J ) 8.8 Hz, 1H, CH-CHdC-N), 5.95 (ddt,
J ) 17.1 Hz, J ) 10.5 Hz, J ) 5.8 Hz, 1H, H2CdCH-
CH2O), 5.35 (dd, J ) 17.1 Hz, J ) 1.3 Hz, 1Htrans, H2Cd
CH-CH2O), 5.25 (d, J ) 10.5 Hz, 1Hcis, H2CdCH-CH2O),
5.28-5.21 (broad m, 1H, NH), 4.87 (broad t, J ) 7.3 Hz,
1H, OCHO), 4.64 (d, J ) 5.5 Hz, 2H, H2CdCH-CH2O),
4.61-4.56 (broad m, 1H, CH-NH), 4.44 (broad s, 1H, NH),
4.17 (2q, J ) 7.0 Hz, 2H, CO2CH2CH3), 3.98 (t, J ) 6.0
Hz, 2H, CH2OPh), 3.93-3.80 (m, 3H, CH2OCHO and OH),
3.59-3.46 (m, 4H, CH2CH2CH2OPh and CHCH2CO2Et and
CH-OH), 3.11 (broad d, J ) 16.3 Hz, 1H, CHCH2CO2Et),
2.39 (dm, J ) 16.3 Hz, 1H, CHCH2CO2Et), 2.02 (quint, J
) 6.3 Hz, 2H, CH2CH2CH2OPh), 1.81 (qd, J ) 8.3 Hz, J )
3.5 Hz, 1H, CH2CHO), 1.71 (dt, J ) 12.8 Hz, J ) 3.0 Hz,
1H, CH2CH2CHO), 1.61-1.46 (m, 4H, 1H from CH2CHO,
1H from CH2CH2CHO and 2H from CH2CH2O), 1.29 (t, J
) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3, 100 MHz):
δ 172.7, 158.4, 152.1, 138.4, 132.3, 120.7, 118.3, 116, 115.84
and 115.82 (1, 2 diastereomers), 113.5 and 113.4 (2
diastereomers), 98.9, 75.2, 66.3, 65.68 and 65.65 (2 diaster-
eomers), 64.0, 62.30 and 62.28 (2 diastereomers), 60.7, 56.2,
54.0, 36.4, 30.6, 29.7, 25.4, 19.57 and 19.55 (2 diastereo-
mers), 14.2. LRMS: MS (ES+) m/z ) 493.2 (M + 1).
Anhydrous sodium bicarbonate (200 mg, 2.37 mmol) and
9-fluorenylmethyl chloroformate (75 mg, 0.28 mmol) were
added to a solution of free amine 12g (84 mg, 0.17 mmol)
in 5 mL of ethyl acetate at room temperature. The reaction
mixture was stirred for 16 h at room temperature, and 3 mL
of water was added. The reaction mixture was stirred for an
additional 3 h, and 9-fluorenylmethyl chloroformate (68 mg,
0.25 mmol) was again added at room temperature and stirred
for 1 h. Then, 5 mL of water was added, and the aqueous
layer was extracted with AcOEt (3 × 10 mL). The organic
layer was dried over MgSO4. After filtration and concentra-
tion under vacuum, the crude product was chromatographed
using the Biotage chromatograph system (A ) hexane, B )
ethyl acetate, CV ) 12 mL, vol fract ) 12 mL, flow ) 7
mL/min, EQ[5CV] 10%B, 1CV[1] 10%B, 10CV[2] 10%B
to 50%B, 10CV[3] 50%B) to give 12h (107 mg, 88%).
Colorless oil. Rf: 0.55 (3/7 hexane/ethyl acetate). 1H NMR
(CDCl3, 400 MHz): δ 7.75 (t, J ) 6.8 Hz, 2H, Ph), 7.49
(broad s, 2H, Ph), 7.39 (q, J ) 7.0 Hz, 2H, Ph), 7.28 (q, J
) 7.0 Hz, 2H, Ph), 6.98 (broad s, 1H, CH-CHdC-N), 6.80
(s, 1H, MEMOC-CHdC), 6.67 (broad d, J ) 7.3 Hz, 1H,
CH-CHdC-N), 6.03-5.89 (m, 1H, H2CdCH-CH2O),
5.36 (d, J ) 17.3 Hz, 1Htrans, H2CdCH-CH2O), 5.25 (d, J
) 10.0 Hz, 1Hcis, H2CdCH-CH2O), 5.13 (dd, J ) 11.3 Hz,
J ) 8.5 Hz, 1H, OCHO), 4.65 (broad d, J ) 5.5 Hz, 2H,
H2CdCH-CH2O), 4.65-4.54 (broad m, 4H, CH-NH and
CHCH2CO2Et and NCOOCH2), 4.51 (broad s, 1H, NH), 4.22
(broad t, J ) 5.8 Hz, 1H, NCOOCH2CH), 4.10-4.00 (m,
4H, CO2CH2CH3 and CH2OPh), 3.97-3.83 (m, 2H, CH2-
OCHO), 3.75 (broad s, 1H, OH), 3.63-3.56 (m, 1H, CH-
OH), 3.54-3.48 (m, 2H, CH2CH2CH2OPh), 2.63 (broad d,
J ) 14.6 Hz, 1H, CHCH2CO2Et), 2.40 (broad dd, J ) 14.6
Hz, J ) 8.5 Hz, 1H, CHCH2CO2Et), 2.07 (quint, J ) 6.0
Hz, 2H, CH2CH2CH2OPh), 1.83 (qd, J ) 8.8 Hz, J ) 3.8
Hz, 1H, CH2CHO), 1.74 (dt, J ) 12.5 Hz, J ) 3.0 Hz, 1H,
CH2CH2CHO), 1.64-1.49 (m, 4H, 1H from CH2CHO, 1H
from CH2CH2CHO and 2H from CH2CH2O), 1.19 (t, J )
7.3 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3, 100 MHz): δ
171.8, 156.9, 156.7, 154.1, 143.66, 143.62, 141.34, 141.31,
132.6, 131.9, 127.69, 127.65 (2C), 127.13, 127.05, 126.7,
124.96, 124.92, 119.90, 119.88, 118.0, 113.04 and 112.94
(2 diastereomers), 110.04 and 109.94 (2 diastereomers), 99.07
and 99.00 (2 diastereomers), 76.7, 67.5, 66.1, 65.22 and 65.18
(2 diastereomers), 63.9, 62.45 and 62.40 (2 diastereomers),
61.0, 57.2, 53.7, 47.2, 38.2, 30.7, 29.67 and 29.63 (2
diastereomers), 25.40 and 25.38 (2 diastereomers), 19.66 and
19.62 (2 diastereomers), 14.0. LRMS: MS (ES+) m/z )
715.4 (M + 1).
Pyridinium p-toluenesulfonate (16 mg, 0.06 mmol) was
added to a solution of THP-protected compound 12g (45 mg,
0.06 mmol) in 8 mL of anhydrous ethanol at room temper-
ature. The reaction mixture was stirred for 2 h at 50 °C.
After it was cooled to room temperature, the reaction mixture
was concentrated under vacuum to remove the ethanol, and
the crude product was chromatographed using the Biotage
chromatograph system (A ) hexane, B ) ethyl acetate, CV
) 12 mL, vol fract ) 15 mL, flow ) 8 mL/min, EQ[5CV]
20%B, 1CV[1] 20%B, 10CV[2] 20%B to 70%B, 10CV[3]
70%B) to give 20 (34 mg, 86%). White solid. Rf: 0.28 (3/7
hexane/ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ 7.75
(t, J ) 7.0 Hz, 2H, Ph), 7.49 (broad s, 2H, Ph), 7.39 (q, J )
7.0 Hz, 2H, Ph), 7.29 (q, J ) 7.0 Hz, 2H, Ph), 6.97 (broad
s, 1H, CH-CHdC-N), 6.80 (s, 1H, MEMOC-CHdC),
6.67 (broad d, J ) 7.5 Hz, 1H, CH-CHdC-N), 6.02-5.88
(m, 1H, H2CdCH-CH2O), 5.35 (d, J ) 17.1 Hz, 1Htrans,
H2CdCH-CH2O), 5.24 (d, J ) 10.0 Hz, 1Hcis, H2CdCH-
CH2O), 5.25 (broad s, 1H, OH), 4.64 (broad d, J ) 5.5 Hz,
2H, H2CdCH-CH2O), 4.65-4.52 (broad m, 4H, CH-NH
and CHCH2CO2Et and NCOOCH2), 4.50 (broad s, 1H, NH),
4.25-4.18 (broad m, 1H, NCOOCH2CH), 4.09 (broad t, J
) 5.5 Hz, 2H, HOCH2CH2CH2O), 4.09-3.99 (m, 2H,
CO2CH2CH3), 3.85 (broad t, J ) 5.5 Hz, 2H, HOCH2CH2-
CH2O), 3.56-3.48 (broad m, 1H, CH-OH), 3.54-3.48 (m,
2H, CH2CH2CH2OPh), 2.60 (broad d, J ) 14.3 Hz, 1H,
CHCH2CO2Et), 2.39 (broad dd, J ) 14.3 Hz, J ) 8.3 Hz,
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1H, CHCH2CO2Et), 2.03 (quint, J ) 5.5 Hz, 2H, HOCH2CH2-
CH2O), 1.18 (t, J ) 7.3 Hz, 3H, CO2CH2CH3). 13C NMR
(CDCl3, 100 MHz): δ 171.8, 156.71, 156.65, 154.1, 143.64,
143.62, 141.33, 141.31, 132.6, 131.9, 127.8, 127.71, 127.67,
127.13, 127.06, 126.7, 124.96, 124.90, 119.91, 119.89, 118.0,
113.2, 110.0, 76.4, 67.5, 66.1, 65.8, 61.0, 60.1, 57.2, 53.7,
47.2, 38.1, 31.9, 14.0. LRMS: MS (ES+) m/z ) 631.3 (M
+ 1).
Solid-Phase Synthesis.
The resin (49.6 mg, 0.064 mmol) and compound 20 (80.8
mg, 0.1281 mmol) were dried on a freeze dryer for 24 h
hours. The beads were placed in a vial, and 1 mL of
anhydrous CH2Cl2 was added at room temperature to allow
the bead to swell. The solution containing the beads was
gently shaken for 30 min. The CH2Cl2 was then removed,
and a 0.45 M of trifluoromethanesulfonate solution (0.85 mL,
0.3843 mmol) was added to the resin and kept for 20 min
(shaking gently). The beads and the solution became an
orange-red color. The trifluoromethanesulfonate solution was
removed completely, and the resin was washed with anhy-
drous CH2Cl2 twice (3 mL). Then 1 mL of anhydrous CH2-
Cl2 was added to the resin, followed by the 2,6-lutidine (60
µL, 0.5124 mmol). The beads became colorless and stood
for 10 min. The compound was dissolved in a minimum of
solvent (0.5 mL of anhydrous CH2Cl2) and added to the resin.
The resulting mixture was gently shaken for 1 h. Then the
vial was capped and kept on tumble shaker for 12 h. The
vial was removed from the tumble shaker, and the mixture
was washed with DCM (5 mL) 3 times, THF 3 times, and
DCM, again, 3 times. Finally, the resin was dried on a
vacuum pump for 6 h and in the freeze dryer for 12 h (62.7
mg, 76%). Rf: 0.36 (1/9 hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 631.2 (M + 1). HPLC: 14.005 min.
The compound loaded onto resin 21 (43.2 mg, 0.0361 mmol)
was swelled in 3 mL of anhydrous CH2Cl2 for 30 min. The
solvent was removed and replaced with 1 mL of anhydrous
CH2Cl2. 1,3-Diisopropylcarbodiimide (34 µL, 0.217 mmol),
4-pentenoic acid (15.2 µL, 0.144 mmol), and 4-(dimethyl-
amino)-pyridine (4.4 mg, 0.0361 mmol) were added at once
to the beads at room temperature. The mixture was shaken
with a tumble shaker for 23 h. The mixture was filtered; the
resin was washed with CH2Cl2 (3 × 5 mL), THF (3 × 5
mL), and CH2Cl2 (3 × 5 mL) and dried under vacuum
overnight. The compound was obtained after the cleavage
of 3 beads. Rf: 0.67 (1/9 hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 713.1 (M + 1). HPLC: 15.771 min. HPLC
yield: 99%.
Resin 21a (21 mg, 0.0181 mmol) was swelled in 3 mL of
anhydrous DMF for 30 min. The solvent was removed and
replaced with 1 mL of anhydrous DMF. Piperidine (100 µL,
1.0 mmol) was added to the beads at room temperature. The
mixture was shaken with a tumble shaker for 17 h. The
mixture was filtered; the resin was washed with THF (3 ×
5 mL), CH2Cl2 (3 × 5 mL), THF (3 × 5 mL), and CH2Cl2
(3 × 5 mL) and dried under vacuum overnight. The
compound was obtained after cleavage of 3 beads. Rf: 0.62
(1/9 hexane/ethyl acetate). LRMS: MS (ES+) m/z ) 491.2
(M + 1). HPLC: 11.125 min. HPLC yield: 85%.
Resin 21b (38.7 mg, 0.0487 mmol) was swelled in 3 mL of
anhydrous CH2Cl2 for 30 min. The solvent was removed and
replaced with 1 mL of anhydrous CH2Cl2. 2,4,6-Collidine
(65 µL, 0.487 mmol) and crotonyl chloride (26.2 µL, 0.243
mmol) were added to the beads at 0 °C. The mixture was
shaken with a tumble shaker for 19 h. The mixture was
filtered; the resin was washed with CH2Cl2 (3 × 5 mL), THF
(3 × 5 mL), and CH2Cl2 (3 × 5 mL) and dried under vacuum
overnight. The compound was obtained after cleavage of 2
beads. Rf: 0.54 (1/9, hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 559.3 (M + 1). HPLC: 9.86 min. HPLC
yield: 99%.
Resin 21c (40 mg, 0.0487 mmol) was swelled in 3 mL of
anhydrous THF for 30 min. The solvent was removed and
replaced with 1 mL of a mixture of anhydrous CH2Cl2 (5
mL), 4-methyl morpholine (0.32 mL), and acetic acid (0.66
mL). Triphenylphosphine (165 mg, 0.621 mmol) and tetrakis-
(triphenylphosphine) palladium (151 mg, 0.130 mmol) were
added to the beads at room temperature. The mixture was
shaken with a tumble shaker for 4 h. The mixture was
filtered; the resin was washed with CH2Cl2 (3 × 5 mL), THF
(3 × 5 mL), and CH2Cl2 (3 × 5 mL) and dried under vacuum
overnight. The compound was obtained after cleavage of 3
beads. Rf: 0.12 (1/9 hexane/ethyl acetate). LRMS: MS
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(ES+) m/z ) 475.3 (M + 1). HPLC: 7.79 min. HPLC
yield: 98%.
Resin 21b (38 mg, 0.0425 mmol) was swelled in 3 mL of
anhydrous CH2Cl2 for 30 min. The solvent was removed and
replaced with 1 mL of anhydrous CH2Cl2. 2,4,6-Collidine
(58.6 µL, 0.425 mmol) and 4-pentenoyl chloride (24 µL,
0.213 mmol) were added to the beads at 0 °C. The mixture
was shaken with a tumble shaker for 14 h. The mixture was
filtered; the resin was washed with CH2Cl2 (3 × 5 mL), THF
(3 × 5 mL), and CH2Cl2 (3 × 5 mL) and dried under vacuum
overnight. The compound was obtained after cleavage of 2
beads. Rf: 0.54 (1/9 hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 573.4 (M + 1). HPLC: 10.15 min. HPLC
yield: 99%.
Resin 21e (40 mg, 0.0425 mmol) was swelled in 3 mL of
anhydrous THF for 30 min. The solvent was removed and
replaced with 1 mL of a mixture of anhydrous CH2Cl2 (5
mL), 4-methyl morpholine (0.32 mL), and acetic acid (0.66
mL). Triphenylphosphine (144 mg, 0.542 mmol) and tetrakis-
(triphenylphosphine) palladium (132 mg, 0.113 mmol) were
added to the beads at room temperature. The mixture was
shaken with a tumble shaker for 14 h. The mixture was
filtered; the resin was washed with CH2Cl2 (3 × 5 mL), THF
(3 × 5 mL), and CH2Cl2 (3 × 5 mL) and dried under vacuum
overnight. The compound was obtained after cleavage of 3
beads. Rf: 0.18 (1/9 hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 489.2 (M + 1), 506.3 (M + 18). HPLC: 8.12
min. HPLC yield: 80%.
Resin 21b (18.6 mg, 0.0181 mmol) was swelled in 3 mL of
anhydrous CH2Cl2 for 30 min. The solvent was removed and
replaced with 1 mL of anhydrous CH2Cl2. 2,4,6-Collidine
(24.1 µL, 0.181 mmol) and benzoyl chloride (10.6 µL, 0.0903
mmol) were added to the beads at room temperature. The
mixture was shaken with a tumble shaker for 16 h. The
mixture was filtered; the resin was washed with CH2Cl2 (3
× 5 mL), THF (3 × 5 mL), and CH2Cl2 (3 × 5 mL) and
dried under vacuum overnight. The compound was obtained
after cleavage of 2 beads. Rf: 0.58 (1/9 hexane/ethyl acetate).
LRMS: MS (ES+) m/z ) 595.2 (M + 1). HPLC: 13.649
min. HPLC yield: 78%.
Resin 21g (19.1 mg, 0.0181 mmol) was swelled in 3 mL of
anhydrous THF for 30 min. The solvent was removed and
replaced with 1 mL of a mixture of anhydrous CH2Cl2 (5
mL), 4-methyl morpholine (0.32 mL), and acetic acid (0.66
mL). Triphenylphosphine (61 mg, 0.230 mmol) and tetrakis-
(triphenylphosphine) palladium (56 mg, 0.048 mmol) were
added to the beads at room temperature. The mixture was
shaken with a tumble shaker for 4 h. The mixture was
filtered; the resin was washed with CH2Cl2 (3 × 5 mL), THF
(3 × 5 mL), and CH2Cl2 (3 × 5 mL) and dried under vacuum
overnight. The compound was obtained after cleavage of 3
beads. Rf: 0.10 (1/9 hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 511.2 (M + 1). HPLC: 2.854 min. HPLC
yield: 71%.
Resin 21d (36 mg, 0.0487 mmol) was swelled in 3 mL of
anhydrous CH2Cl2 for 30 min. The solvent was removed and
replaced with 1 mL of anhydrous CH2Cl2. 2,4,6-Collidine
(65 µL, 0.487 mmol) and benzoyl chloride (28.5 µL, 0.243
mmol) were added to the beads at room temperature. The
mixture was shaken with a tumble shaker for 19 h. The
mixture was filtered; the resin was washed with CH2Cl2 (3
× 5 mL), THF (3 × 5 mL), and CH2Cl2 (3 × 5 mL) and
dried under vacuum overnight. The compound was obtained
after cleavage of 2 beads. Rf: 0.48 (1/9 hexane/ethyl acetate).
LRMS: MS (ES+) m/z ) 579.2 (M + 1). HPLC: 9.88 min.
HPLC yield: 90%.
Resin 22 (38 mg, 0.487 mmol) was swelled in 2 mL of
anhydrous CH2Cl2 for 30 min. Second-generation Grubbs’
catalyst (41 mg, 0.0487 mmol) was added to the beads at
room temperature. The mixture was heated to reflux for 19
h. After it was cooled, the mixture was filtered, and the resin
was washed with THF (3 × 5 mL), CH2Cl2 (3 × 5 mL),
THF (3 × 5 mL), and CH2Cl2 (3 × 5 mL) and dried under
vacuum overnight. The compound was obtained after cleav-
age of 3 beads. Rf: 0.14 (1/9 hexane/ethyl acetate). LRMS:
MS (ES+) m/z ) 537.3 (M + 1). HPLC: 8.71 min. After
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cleavage of all resin 22a, the crude product was chromato-
graphed on silica gel (eluent ) hexane/ethyl acetate, 1/9 to
pure ethyl acetate) to give the title compound as a white
solid.
Resin 21f (35 mg, 0.0425 mmol) was swelled in 3 mL of
anhydrous CH2Cl2 for 30 min. The solvent was removed and
replaced with 1 mL of anhydrous CH2Cl2. 2,4,6-Collidine
(57 µL, 0.425 mmol) and benzoyl chloride (25 µL, 0.213
mmol) were added to the beads at room temperature. The
mixture was shaken with a tumble shaker for 19 h. The
mixture was filtered, and the resin was washed with CH2Cl2
(3 × 5 mL), THF (3 × 5 mL), and CH2Cl2 (3 × 5 mL) and
dried under vacuum overnight. The compound was obtained
after cleavage of 2 beads. Rf: 0.53 (1/9 hexane/ethyl acetate).
LRMS: MS (ES+) m/z ) 593.3 (M + 1), 610.4 (M + 18).
HPLC: 10.12 min. HPLC yield: 90%.
Resin 24 (38 mg, 0.425 mmol) was swelled in 2 mL of
anhydrous CH2Cl2 for 30 min. Second-generation Grubbs
catalyst (36 mg, 0.0425 mmol) was added to the beads at
room temperature. The mixture was heated to reflux for 17
h. After it was cooled, the mixture was filtered, and the resin
was washed with THF (3 × 5 mL), CH2Cl2 (3 × 5 mL),
THF (3 × 5 mL), and CH2Cl2 (3 × 5 mL) and dried under
vacuum overnight. The compound was obtained after cleav-
age of 3 beads. Rf: 0.10 (1/9 hexane/ethyl acetate). LRMS:
MS (ES+) m/z ) 565.2 (M + 1), 582.3 (M + 18). HPLC:
9.17 min. After cleavage of all resin 24a, the crude product
was chromatographed on silica gel (eluent ) hexane/ethyl
acetate, 1/9 to pure ethyl acetate) to give the title compound
as a white solid.
Resin 21h (16.4 mg, 0.0181 mmol) was swelled in 3 mL of
anhydrous CH2Cl2 for 30 min. The solvent was removed and
replaced with 1 mL of anhydrous CH2Cl2. 2,4,6-Collidine
(24.1 µL, 0.181 mmol ) and 4-pentenoyl choloride (10.2 µL,
0.0903 mmol) were added to the beads at room temperature.
The mixture was shaken with a tumble shaker for 2 days.
The mixture was filtered, and the resin was washed with
CH2Cl2 (3 × 5 mL), THF (3 × 5 mL) and CH2Cl2 (3 × 5
mL) and dried under vacuum overnight. The compound was
obtained after cleavage of 3 beads. Rf: 0.49 (1/9 hexane/
ethyl acetate). LRMS: MS (ES+) m/z ) 593.3 (M + 1).
HPLC: 11.971 min. HPLC yield: 81%.
Resin 26 (17.9 mg, 0.0181 mmol) was swelled in 2 mL of
anhydrous CH2Cl2 for 30 min. Second-generation Grubbs
catalyst (3 mg, 0.0036 mmol) was added to the beads at room
temperature. The mixture was heated to reflux for 19 h. After
it was cooled, the mixture was filtered, and the resin was
washed with THF (3 × 5 mL), CH2Cl2 (3 × 5 mL), THF (3
× 5 mL), and CH2Cl2 (3 × 5 mL) and dried under vacuum
overnight. The compound was obtained after cleavage of 3
beads. Rf: 0.16 (1/9 hexane/ethyl acetate). LRMS: MS
(ES+) m/z ) 565.2 (M + 1). HPLC: 3.883 min.
After cleavage of all resin 26a, the crude product was purified
using the Biotage chromatograph system (A ) hexane, B )
ethyl acetate, CV ) 12 mL, vol fract ) 12 mL, flow ) 4
mL/min, EQ[5CV] 23%B, 1CV[1] 23%B, 10CV[2] 230%B
to 90%B, 10CV[3] 90%B) to give the title compound (5.8
mg, 57%) (Figure 12). White solid. Rf: 0.16 (1/9, hexane/
ethyl acetate). 1H NMR (CDCl3, 400 MHz): δ 7.36-7.20
(m, 5H, HPh), 6.80 (broad d, J ) 2.0 Hz, 1H, MEMOC-
CHdC), 6.48 (dd, J ) 8.5 Hz, J ) 2.0 Hz, 1H, CH-CHd
C-N), 6.41 (d, J ) 8.5 Hz, 1H, CH-CHdC-N), 5.79 (d,
J ) 9.0 Hz, 1H, NH), 5.54-5.42 (m, 2H, CH2CHdCHCH2),
5.38 (dd, J ) 10.0 Hz, J ) 9.0 Hz, 1H, CH-NH), 5.16-
5.10 (m, 1H, CHCH2CO2Et), 5.09 (dd, J ) 10.5 Hz, J )
4.5 Hz, 1H, CHOCO), 4.07-3.98 (m, 4H, CH2CH2O and
CO2CH2CH3), 3.84 (t, J ) 6.0 Hz, 1H, CH2OH), 2.70-2.31
(m, 9H, 7H from NHCOCH2CH2CHdCHCH2CH2 and 2H
from CHCH2CO2Et), 2.16 (td, J ) 12.0 Hz, J ) 2.5 Hz,
Figure 12. NOESY of compound 27 showing NOEs between H2
and H4 and NH and H4.
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1H, NHCOCH2), 2.01 (quint, J ) 6.0 Hz, 2H, CH2CH2O),
1.21 (t, J ) 7.0 Hz, 3H, CO2CH2CH3). 13C NMR (CDCl3,
100 MHz): δ 173.5, 173.0, 169.8, 169.0, 157.3, 134.5, 131.4,
130.7, 130.6, 130.4, 130.1, 128.9 (2C), 128.1 (2C), 127.6,
112.8, 110.6, 76.3, 65.7, 60.9, 60.1, 54.7, 50.9, 38.3, 37.9,
34.4, 31.9, 29.5, 28.6, 14.1. LRMS: MS (ES+) m/z ) 565.3
(M + 1). HPLC: 3.883 min.
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